| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatectomy | 46 | 2023 | 1782 | 2.510 |
Why?
|
| Models, Statistical | 47 | 2023 | 5089 | 2.480 |
Why?
|
| Biometry | 32 | 2019 | 571 | 2.390 |
Why?
|
| Prostatic Neoplasms | 78 | 2025 | 11083 | 2.230 |
Why?
|
| Surgical Procedures, Operative | 40 | 2024 | 1941 | 1.900 |
Why?
|
| Cystectomy | 16 | 2020 | 604 | 1.630 |
Why?
|
| Urinary Bladder Neoplasms | 23 | 2024 | 2176 | 1.440 |
Why?
|
| Checklist | 19 | 2024 | 848 | 1.360 |
Why?
|
| Regression Analysis | 30 | 2019 | 6322 | 1.310 |
Why?
|
| Prostate-Specific Antigen | 17 | 2024 | 2464 | 1.310 |
Why?
|
| Data Interpretation, Statistical | 30 | 2022 | 2686 | 1.280 |
Why?
|
| Likelihood Functions | 24 | 2023 | 993 | 1.280 |
Why?
|
| Bayes Theorem | 9 | 2022 | 2354 | 1.270 |
Why?
|
| Healthcare Disparities | 27 | 2024 | 3413 | 1.240 |
Why?
|
| General Surgery | 23 | 2021 | 1722 | 1.070 |
Why?
|
| Electronic Health Records | 27 | 2024 | 4873 | 1.040 |
Why?
|
| Hospitals | 34 | 2024 | 3888 | 1.040 |
Why?
|
| Medical Errors | 18 | 2024 | 1260 | 0.980 |
Why?
|
| Humans | 609 | 2025 | 765968 | 0.950 |
Why?
|
| Quality Improvement | 30 | 2024 | 3853 | 0.950 |
Why?
|
| Accidental Falls | 10 | 2023 | 1078 | 0.950 |
Why?
|
| Male | 390 | 2025 | 363698 | 0.920 |
Why?
|
| Quality Indicators, Health Care | 20 | 2024 | 1806 | 0.910 |
Why?
|
| Aged | 257 | 2025 | 171117 | 0.860 |
Why?
|
| Postoperative Complications | 53 | 2024 | 15747 | 0.850 |
Why?
|
| United States | 169 | 2025 | 72903 | 0.840 |
Why?
|
| SEER Program | 27 | 2024 | 1446 | 0.810 |
Why?
|
| Robotics | 16 | 2012 | 809 | 0.800 |
Why?
|
| Patient Discharge | 15 | 2024 | 3461 | 0.790 |
Why?
|
| Medicare | 42 | 2024 | 6823 | 0.790 |
Why?
|
| Female | 365 | 2025 | 396112 | 0.770 |
Why?
|
| Hospital Mortality | 24 | 2023 | 5343 | 0.740 |
Why?
|
| Operating Rooms | 15 | 2020 | 788 | 0.720 |
Why?
|
| Middle Aged | 244 | 2025 | 223009 | 0.720 |
Why?
|
| Clinical Competence | 23 | 2021 | 4863 | 0.710 |
Why?
|
| Logistic Models | 47 | 2025 | 13266 | 0.710 |
Why?
|
| Nephrectomy | 9 | 2020 | 927 | 0.710 |
Why?
|
| Decision Support Systems, Clinical | 10 | 2024 | 1175 | 0.710 |
Why?
|
| Algorithms | 21 | 2024 | 14071 | 0.700 |
Why?
|
| Survival Analysis | 29 | 2022 | 10070 | 0.680 |
Why?
|
| Linear Models | 27 | 2024 | 5876 | 0.660 |
Why?
|
| Computer Simulation | 30 | 2023 | 6255 | 0.660 |
Why?
|
| Patient Readmission | 18 | 2022 | 3286 | 0.660 |
Why?
|
| Terminal Care | 12 | 2023 | 1774 | 0.660 |
Why?
|
| Laparoscopy | 18 | 2023 | 2039 | 0.650 |
Why?
|
| Prostate | 9 | 2023 | 1755 | 0.650 |
Why?
|
| Early Detection of Cancer | 15 | 2025 | 3236 | 0.640 |
Why?
|
| Arthroplasty, Replacement, Knee | 11 | 2023 | 1379 | 0.640 |
Why?
|
| Inpatients | 15 | 2024 | 2564 | 0.620 |
Why?
|
| Binomial Distribution | 2 | 2014 | 23 | 0.620 |
Why?
|
| Medication Errors | 8 | 2023 | 786 | 0.620 |
Why?
|
| Multivariate Analysis | 31 | 2024 | 12056 | 0.610 |
Why?
|
| Cluster Analysis | 15 | 2024 | 2721 | 0.600 |
Why?
|
| Health Services Accessibility | 21 | 2025 | 5508 | 0.590 |
Why?
|
| Patient Care Team | 14 | 2024 | 2517 | 0.580 |
Why?
|
| Retrospective Studies | 118 | 2024 | 81514 | 0.580 |
Why?
|
| Primary Health Care | 13 | 2024 | 4736 | 0.560 |
Why?
|
| Adult | 190 | 2025 | 223044 | 0.550 |
Why?
|
| Hospitalization | 23 | 2024 | 10808 | 0.550 |
Why?
|
| Antibiotics, Antineoplastic | 11 | 2012 | 679 | 0.550 |
Why?
|
| Normal Distribution | 4 | 2022 | 267 | 0.550 |
Why?
|
| Urology | 3 | 2017 | 384 | 0.530 |
Why?
|
| Venous Thromboembolism | 4 | 2024 | 1882 | 0.530 |
Why?
|
| Patient-Centered Care | 10 | 2021 | 1458 | 0.530 |
Why?
|
| Neoplasms | 34 | 2025 | 22340 | 0.530 |
Why?
|
| Mammaplasty | 12 | 2016 | 1264 | 0.520 |
Why?
|
| Breast Neoplasms | 35 | 2025 | 21056 | 0.500 |
Why?
|
| Proportional Hazards Models | 21 | 2021 | 12509 | 0.500 |
Why?
|
| Health Care Costs | 13 | 2023 | 3242 | 0.480 |
Why?
|
| Wounds and Injuries | 11 | 2020 | 2511 | 0.480 |
Why?
|
| Doxorubicin | 15 | 2013 | 2230 | 0.470 |
Why?
|
| Aged, 80 and over | 84 | 2024 | 59489 | 0.470 |
Why?
|
| Health Care Surveys | 12 | 2019 | 2424 | 0.470 |
Why?
|
| Comparative Effectiveness Research | 4 | 2018 | 714 | 0.460 |
Why?
|
| Length of Stay | 30 | 2024 | 6485 | 0.460 |
Why?
|
| Quality of Health Care | 19 | 2024 | 4300 | 0.460 |
Why?
|
| Space Flight | 3 | 2022 | 219 | 0.460 |
Why?
|
| Delivery, Obstetric | 7 | 2024 | 946 | 0.460 |
Why?
|
| Attitude of Health Personnel | 15 | 2024 | 3925 | 0.460 |
Why?
|
| Kidney Neoplasms | 9 | 2024 | 4274 | 0.460 |
Why?
|
| Kallikreins | 2 | 2017 | 220 | 0.450 |
Why?
|
| Emergency Treatment | 6 | 2020 | 494 | 0.450 |
Why?
|
| Hypertension | 14 | 2024 | 8626 | 0.440 |
Why?
|
| Risk Assessment | 46 | 2024 | 24282 | 0.440 |
Why?
|
| Tourniquets | 3 | 2019 | 111 | 0.440 |
Why?
|
| Risk | 11 | 2017 | 9591 | 0.440 |
Why?
|
| Medically Uninsured | 8 | 2018 | 838 | 0.430 |
Why?
|
| Physicians | 13 | 2024 | 4588 | 0.420 |
Why?
|
| Longitudinal Studies | 31 | 2023 | 14751 | 0.410 |
Why?
|
| Guideline Adherence | 13 | 2020 | 2243 | 0.410 |
Why?
|
| Internship and Residency | 15 | 2021 | 5946 | 0.400 |
Why?
|
| Treatment Outcome | 82 | 2024 | 65188 | 0.400 |
Why?
|
| Hospital Costs | 7 | 2017 | 956 | 0.400 |
Why?
|
| Propensity Score | 13 | 2023 | 1968 | 0.400 |
Why?
|
| Monte Carlo Method | 8 | 2019 | 1238 | 0.400 |
Why?
|
| Arthroplasty, Replacement, Hip | 6 | 2022 | 1416 | 0.400 |
Why?
|
| Prostatic Hyperplasia | 3 | 2024 | 515 | 0.400 |
Why?
|
| Infusion Pumps | 4 | 2023 | 163 | 0.390 |
Why?
|
| Research Design | 13 | 2023 | 6209 | 0.390 |
Why?
|
| Carcinoma, Transitional Cell | 4 | 2021 | 790 | 0.380 |
Why?
|
| Survival Rate | 30 | 2021 | 12795 | 0.380 |
Why?
|
| Lymph Node Excision | 8 | 2019 | 1259 | 0.380 |
Why?
|
| Liver Transplantation | 2 | 2023 | 2412 | 0.380 |
Why?
|
| Communication | 14 | 2023 | 3916 | 0.370 |
Why?
|
| Drug Prescriptions | 5 | 2024 | 1662 | 0.370 |
Why?
|
| Educational Measurement | 6 | 2021 | 1260 | 0.370 |
Why?
|
| Learning Curve | 4 | 2020 | 232 | 0.370 |
Why?
|
| Pain, Postoperative | 6 | 2021 | 1772 | 0.370 |
Why?
|
| Colorectal Neoplasms | 14 | 2025 | 6942 | 0.370 |
Why?
|
| Patient Satisfaction | 10 | 2019 | 3475 | 0.360 |
Why?
|
| Electronic Mail | 4 | 2023 | 216 | 0.360 |
Why?
|
| Military Medicine | 3 | 2017 | 185 | 0.360 |
Why?
|
| Diffusion of Innovation | 5 | 2018 | 721 | 0.360 |
Why?
|
| Maternal Health Services | 4 | 2022 | 472 | 0.360 |
Why?
|
| Kidney Transplantation | 3 | 2023 | 4270 | 0.360 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 14 | 2013 | 1560 | 0.350 |
Why?
|
| World Health Organization | 12 | 2020 | 1328 | 0.340 |
Why?
|
| Medicaid | 8 | 2023 | 2833 | 0.340 |
Why?
|
| Palliative Care | 7 | 2024 | 3645 | 0.340 |
Why?
|
| Cross-Sectional Studies | 41 | 2025 | 26318 | 0.340 |
Why?
|
| Neoplasm Staging | 27 | 2021 | 11206 | 0.340 |
Why?
|
| Specialties, Surgical | 4 | 2023 | 391 | 0.340 |
Why?
|
| Behavioral Risk Factor Surveillance System | 5 | 2025 | 212 | 0.340 |
Why?
|
| Health Knowledge, Attitudes, Practice | 10 | 2024 | 4058 | 0.340 |
Why?
|
| Time Factors | 52 | 2024 | 40065 | 0.340 |
Why?
|
| Patient Participation | 7 | 2024 | 1455 | 0.340 |
Why?
|
| Ambulatory Surgical Procedures | 4 | 2024 | 453 | 0.330 |
Why?
|
| Chi-Square Distribution | 15 | 2023 | 3432 | 0.330 |
Why?
|
| Infusions, Intravenous | 10 | 2023 | 2229 | 0.330 |
Why?
|
| Intensive Care Units | 7 | 2023 | 3800 | 0.330 |
Why?
|
| Physicians, Primary Care | 4 | 2024 | 622 | 0.330 |
Why?
|
| Patient Acceptance of Health Care | 9 | 2020 | 3230 | 0.330 |
Why?
|
| Clinical Trials as Topic | 11 | 2018 | 8041 | 0.320 |
Why?
|
| Neoadjuvant Therapy | 8 | 2019 | 2895 | 0.320 |
Why?
|
| Survivors | 13 | 2023 | 2372 | 0.320 |
Why?
|
| Razoxane | 4 | 2012 | 43 | 0.320 |
Why?
|
| Socioeconomic Factors | 22 | 2025 | 7838 | 0.310 |
Why?
|
| Health Expenditures | 9 | 2023 | 2387 | 0.310 |
Why?
|
| Urinary Bladder | 7 | 2023 | 1154 | 0.310 |
Why?
|
| Fee-for-Service Plans | 4 | 2017 | 716 | 0.310 |
Why?
|
| Emergencies | 6 | 2022 | 1223 | 0.310 |
Why?
|
| Medical Oncology | 3 | 2019 | 2339 | 0.310 |
Why?
|
| Dementia | 5 | 2024 | 2744 | 0.310 |
Why?
|
| Analgesics, Opioid | 8 | 2024 | 3835 | 0.300 |
Why?
|
| Electronics | 7 | 2022 | 314 | 0.300 |
Why?
|
| Accidents, Occupational | 1 | 2010 | 251 | 0.300 |
Why?
|
| Mastectomy | 10 | 2020 | 1847 | 0.300 |
Why?
|
| Risk Factors | 66 | 2024 | 74840 | 0.290 |
Why?
|
| Video Recording | 5 | 2021 | 969 | 0.290 |
Why?
|
| Trauma Centers | 6 | 2021 | 952 | 0.290 |
Why?
|
| Antihypertensive Agents | 5 | 2024 | 2033 | 0.290 |
Why?
|
| Muscle Neoplasms | 2 | 2019 | 130 | 0.290 |
Why?
|
| Fontan Procedure | 2 | 2024 | 805 | 0.290 |
Why?
|
| Prospective Studies | 52 | 2024 | 54802 | 0.280 |
Why?
|
| Advance Care Planning | 4 | 2019 | 702 | 0.280 |
Why?
|
| Mastectomy, Segmental | 5 | 2017 | 964 | 0.280 |
Why?
|
| Analysis of Variance | 14 | 2016 | 6203 | 0.280 |
Why?
|
| Intraoperative Complications | 6 | 2013 | 1162 | 0.280 |
Why?
|
| Delivery of Health Care | 6 | 2023 | 5370 | 0.280 |
Why?
|
| Safety Management | 7 | 2013 | 763 | 0.280 |
Why?
|
| Education, Medical, Graduate | 7 | 2021 | 2418 | 0.280 |
Why?
|
| Patient Protection and Affordable Care Act | 7 | 2023 | 1188 | 0.270 |
Why?
|
| Magnetic Resonance Imaging, Cine | 2 | 2024 | 1094 | 0.270 |
Why?
|
| Vascular Surgical Procedures | 7 | 2020 | 1485 | 0.270 |
Why?
|
| Statistics as Topic | 6 | 2014 | 2352 | 0.260 |
Why?
|
| Androgen Antagonists | 4 | 2019 | 1411 | 0.260 |
Why?
|
| Quality Assurance, Health Care | 8 | 2017 | 2172 | 0.260 |
Why?
|
| Diabetes Complications | 5 | 2014 | 1316 | 0.260 |
Why?
|
| Confidence Intervals | 10 | 2014 | 2910 | 0.260 |
Why?
|
| Databases, Factual | 23 | 2020 | 8067 | 0.260 |
Why?
|
| Odds Ratio | 20 | 2025 | 9649 | 0.260 |
Why?
|
| Hospitals, Community | 4 | 2024 | 363 | 0.260 |
Why?
|
| Watchful Waiting | 3 | 2023 | 493 | 0.250 |
Why?
|
| Maternal Mortality | 6 | 2020 | 313 | 0.250 |
Why?
|
| Cocaine-Related Disorders | 2 | 2020 | 459 | 0.250 |
Why?
|
| Colectomy | 7 | 2022 | 697 | 0.250 |
Why?
|
| Nurses | 5 | 2020 | 2505 | 0.250 |
Why?
|
| Oximetry | 3 | 2015 | 459 | 0.250 |
Why?
|
| Renal Insufficiency, Chronic | 4 | 2024 | 2310 | 0.250 |
Why?
|
| Cohort Studies | 34 | 2024 | 41649 | 0.250 |
Why?
|
| Laser Therapy | 2 | 2023 | 1108 | 0.250 |
Why?
|
| Muscles | 3 | 2019 | 1578 | 0.250 |
Why?
|
| Workload | 5 | 2016 | 851 | 0.240 |
Why?
|
| Clinical Trials, Phase III as Topic | 3 | 2010 | 878 | 0.240 |
Why?
|
| Perinatal Mortality | 3 | 2020 | 103 | 0.240 |
Why?
|
| Patient Compliance | 5 | 2025 | 2692 | 0.240 |
Why?
|
| Chemotherapy, Adjuvant | 9 | 2019 | 3537 | 0.240 |
Why?
|
| Patient Care | 4 | 2024 | 629 | 0.240 |
Why?
|
| Poisson Distribution | 4 | 2015 | 508 | 0.240 |
Why?
|
| Hemorrhage | 5 | 2022 | 3461 | 0.240 |
Why?
|
| Critical Care | 7 | 2023 | 2712 | 0.240 |
Why?
|
| Developing Countries | 6 | 2021 | 2911 | 0.240 |
Why?
|
| Quality of Life | 12 | 2023 | 13462 | 0.230 |
Why?
|
| Colorectal Surgery | 2 | 2024 | 125 | 0.230 |
Why?
|
| Appendectomy | 3 | 2019 | 444 | 0.230 |
Why?
|
| Appendicitis | 3 | 2019 | 679 | 0.230 |
Why?
|
| Surgery, Computer-Assisted | 5 | 2012 | 993 | 0.230 |
Why?
|
| Transurethral Resection of Prostate | 3 | 2022 | 76 | 0.230 |
Why?
|
| Follow-Up Studies | 37 | 2021 | 39193 | 0.230 |
Why?
|
| Postoperative Period | 5 | 2021 | 1816 | 0.230 |
Why?
|
| Cesarean Section | 6 | 2022 | 1431 | 0.230 |
Why?
|
| Hospitals, Pediatric | 5 | 2024 | 1846 | 0.230 |
Why?
|
| Occupations | 2 | 2017 | 516 | 0.220 |
Why?
|
| Patient Simulation | 2 | 2018 | 301 | 0.220 |
Why?
|
| Statistics, Nonparametric | 7 | 2019 | 2844 | 0.220 |
Why?
|
| Uterine Cervical Neoplasms | 5 | 2025 | 2047 | 0.220 |
Why?
|
| Ischemia | 6 | 2013 | 1909 | 0.220 |
Why?
|
| Anthracyclines | 3 | 2012 | 284 | 0.220 |
Why?
|
| Hospice Care | 3 | 2023 | 678 | 0.220 |
Why?
|
| Erectile Dysfunction | 6 | 2017 | 437 | 0.220 |
Why?
|
| Rectal Neoplasms | 4 | 2020 | 1182 | 0.220 |
Why?
|
| Child | 66 | 2024 | 80564 | 0.220 |
Why?
|
| South Carolina | 8 | 2017 | 113 | 0.220 |
Why?
|
| Heart Diseases | 10 | 2013 | 2821 | 0.220 |
Why?
|
| Reproducibility of Results | 19 | 2024 | 20124 | 0.220 |
Why?
|
| Health Education | 2 | 2021 | 1060 | 0.220 |
Why?
|
| Neoplasm Invasiveness | 10 | 2019 | 3602 | 0.220 |
Why?
|
| Ventricular Function, Left | 10 | 2024 | 3928 | 0.220 |
Why?
|
| Physician-Patient Relations | 6 | 2019 | 3278 | 0.210 |
Why?
|
| Randomized Controlled Trials as Topic | 16 | 2022 | 10383 | 0.210 |
Why?
|
| Adolescent | 61 | 2024 | 88835 | 0.210 |
Why?
|
| Benchmarking | 8 | 2018 | 1052 | 0.210 |
Why?
|
| Ethics Consultation | 1 | 2024 | 59 | 0.210 |
Why?
|
| Surgery Department, Hospital | 4 | 2012 | 170 | 0.210 |
Why?
|
| Minority Groups | 7 | 2024 | 1207 | 0.210 |
Why?
|
| Cardiotoxins | 2 | 2013 | 35 | 0.210 |
Why?
|
| Patient Admission | 3 | 2024 | 1365 | 0.210 |
Why?
|
| Ventricular Septum | 1 | 2023 | 76 | 0.210 |
Why?
|
| Artificial Limbs | 1 | 2024 | 121 | 0.210 |
Why?
|
| Extremities | 3 | 2018 | 869 | 0.210 |
Why?
|
| Young Adult | 38 | 2025 | 59889 | 0.210 |
Why?
|
| Decision Support Techniques | 3 | 2018 | 2003 | 0.210 |
Why?
|
| Attitude to Computers | 4 | 2018 | 196 | 0.210 |
Why?
|
| Efficiency | 3 | 2016 | 480 | 0.210 |
Why?
|
| Erythroblasts | 1 | 2023 | 142 | 0.210 |
Why?
|
| Medical Records Systems, Computerized | 4 | 2009 | 1195 | 0.210 |
Why?
|
| Data Mining | 3 | 2013 | 562 | 0.200 |
Why?
|
| Reimbursement Mechanisms | 2 | 2019 | 672 | 0.200 |
Why?
|
| Boston | 20 | 2021 | 9338 | 0.200 |
Why?
|
| Iodine | 3 | 2022 | 288 | 0.200 |
Why?
|
| Respiratory Insufficiency | 2 | 2022 | 1240 | 0.200 |
Why?
|
| Pharmaceutical Preparations | 5 | 2023 | 1084 | 0.200 |
Why?
|
| Population Surveillance | 3 | 2010 | 2590 | 0.200 |
Why?
|
| Medical Audit | 4 | 2016 | 452 | 0.200 |
Why?
|
| Astronauts | 2 | 2022 | 94 | 0.200 |
Why?
|
| Military Personnel | 6 | 2019 | 1252 | 0.200 |
Why?
|
| Pulmonary Atresia | 1 | 2023 | 159 | 0.200 |
Why?
|
| Urethral Obstruction | 1 | 2022 | 56 | 0.200 |
Why?
|
| First Aid | 2 | 2019 | 71 | 0.200 |
Why?
|
| Surgery, Plastic | 3 | 2016 | 651 | 0.200 |
Why?
|
| Esophagectomy | 2 | 2020 | 477 | 0.200 |
Why?
|
| Medication Systems, Hospital | 3 | 2018 | 154 | 0.200 |
Why?
|
| Registries | 10 | 2023 | 8297 | 0.200 |
Why?
|
| Predictive Value of Tests | 16 | 2024 | 15398 | 0.200 |
Why?
|
| Documentation | 4 | 2024 | 916 | 0.190 |
Why?
|
| Least-Squares Analysis | 4 | 1998 | 368 | 0.190 |
Why?
|
| Hip Fractures | 2 | 2024 | 997 | 0.190 |
Why?
|
| Cryotherapy | 2 | 2014 | 164 | 0.190 |
Why?
|
| Ambulatory Care | 5 | 2024 | 2778 | 0.190 |
Why?
|
| Probability | 12 | 2023 | 2475 | 0.190 |
Why?
|
| Independent Living | 2 | 2024 | 585 | 0.190 |
Why?
|
| Perception | 3 | 2018 | 1205 | 0.190 |
Why?
|
| Infant, Low Birth Weight | 2 | 2023 | 871 | 0.190 |
Why?
|
| Urination | 3 | 2012 | 204 | 0.190 |
Why?
|
| Telephone | 3 | 2014 | 627 | 0.190 |
Why?
|
| Age Factors | 20 | 2018 | 18380 | 0.190 |
Why?
|
| Medical Order Entry Systems | 3 | 2013 | 521 | 0.190 |
Why?
|
| Hospital Information Systems | 2 | 2017 | 396 | 0.190 |
Why?
|
| Massachusetts | 15 | 2024 | 8875 | 0.190 |
Why?
|
| Aftercare | 4 | 2023 | 911 | 0.190 |
Why?
|
| Radiotherapy, Adjuvant | 8 | 2017 | 1776 | 0.190 |
Why?
|
| Program Evaluation | 7 | 2018 | 2499 | 0.180 |
Why?
|
| Aerospace Medicine | 1 | 2022 | 95 | 0.180 |
Why?
|
| Patient Education as Topic | 5 | 2024 | 2334 | 0.180 |
Why?
|
| Echocardiography | 15 | 2013 | 5045 | 0.180 |
Why?
|
| Comorbidity | 14 | 2018 | 10563 | 0.180 |
Why?
|
| Biostatistics | 3 | 2015 | 162 | 0.180 |
Why?
|
| Behavior Therapy | 3 | 2014 | 884 | 0.180 |
Why?
|
| Peer Group | 2 | 2020 | 701 | 0.180 |
Why?
|
| Health Records, Personal | 2 | 2012 | 126 | 0.180 |
Why?
|
| Access to Information | 1 | 2023 | 317 | 0.170 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 14 | 2019 | 11868 | 0.170 |
Why?
|
| Age Distribution | 10 | 2013 | 2858 | 0.170 |
Why?
|
| Sex Distribution | 9 | 2016 | 2263 | 0.170 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2020 | 953 | 0.170 |
Why?
|
| Carcinoma, Ductal, Breast | 4 | 2012 | 1083 | 0.170 |
Why?
|
| Hospital Administration | 2 | 2014 | 352 | 0.170 |
Why?
|
| Sex Factors | 15 | 2024 | 10603 | 0.170 |
Why?
|
| Preoperative Care | 5 | 2016 | 2267 | 0.170 |
Why?
|
| Preventive Health Services | 2 | 2018 | 570 | 0.170 |
Why?
|
| Delayed Diagnosis | 1 | 2024 | 452 | 0.170 |
Why?
|
| Psychotherapy | 2 | 2020 | 1645 | 0.170 |
Why?
|
| Nurse Midwives | 1 | 2020 | 24 | 0.170 |
Why?
|
| Ureteral Neoplasms | 1 | 2021 | 106 | 0.170 |
Why?
|
| Combined Modality Therapy | 15 | 2019 | 8529 | 0.170 |
Why?
|
| Opiate Substitution Treatment | 1 | 2024 | 452 | 0.170 |
Why?
|
| Pandemics | 10 | 2024 | 8703 | 0.170 |
Why?
|
| Heart Defects, Congenital | 4 | 2024 | 4697 | 0.170 |
Why?
|
| Convalescence | 1 | 2020 | 107 | 0.160 |
Why?
|
| Mars | 1 | 2019 | 29 | 0.160 |
Why?
|
| Pulmonary Valve | 1 | 2023 | 413 | 0.160 |
Why?
|
| Urinary Incontinence | 6 | 2017 | 491 | 0.160 |
Why?
|
| Leadership | 6 | 2021 | 1392 | 0.160 |
Why?
|
| Software | 8 | 2023 | 4462 | 0.160 |
Why?
|
| Heart | 8 | 2024 | 4414 | 0.160 |
Why?
|
| Injury Severity Score | 7 | 2020 | 1050 | 0.160 |
Why?
|
| Diabetes Mellitus | 5 | 2022 | 5891 | 0.160 |
Why?
|
| Telemedicine | 3 | 2024 | 3105 | 0.160 |
Why?
|
| Diverticulitis | 1 | 2022 | 187 | 0.160 |
Why?
|
| Thinness | 1 | 2023 | 482 | 0.160 |
Why?
|
| Renal Replacement Therapy | 1 | 2021 | 281 | 0.160 |
Why?
|
| Troponin T | 7 | 2012 | 785 | 0.160 |
Why?
|
| Acinetobacter Infections | 1 | 2019 | 74 | 0.160 |
Why?
|
| Respiratory Sounds | 8 | 2006 | 705 | 0.160 |
Why?
|
| Tracheostomy | 1 | 2023 | 429 | 0.160 |
Why?
|
| Brachytherapy | 3 | 2018 | 1222 | 0.160 |
Why?
|
| Labor, Obstetric | 2 | 2024 | 317 | 0.160 |
Why?
|
| Sample Size | 4 | 2014 | 845 | 0.160 |
Why?
|
| Veterans | 5 | 2022 | 2664 | 0.160 |
Why?
|
| Cancer Care Facilities | 4 | 2018 | 426 | 0.160 |
Why?
|
| Residence Characteristics | 4 | 2022 | 2116 | 0.160 |
Why?
|
| Thoracic Outlet Syndrome | 1 | 2020 | 97 | 0.160 |
Why?
|
| Family Practice | 1 | 2002 | 508 | 0.160 |
Why?
|
| CD4 Lymphocyte Count | 3 | 2010 | 2587 | 0.160 |
Why?
|
| Blood Pressure | 8 | 2021 | 8532 | 0.160 |
Why?
|
| India | 7 | 2020 | 2334 | 0.160 |
Why?
|
| Insurance Coverage | 7 | 2023 | 1944 | 0.160 |
Why?
|
| Prosthesis Design | 2 | 2024 | 2105 | 0.150 |
Why?
|
| Tibia | 1 | 2024 | 1062 | 0.150 |
Why?
|
| Urban Health | 2 | 2006 | 530 | 0.150 |
Why?
|
| Adenocarcinoma | 8 | 2017 | 6364 | 0.150 |
Why?
|
| Heart Valve Prosthesis Implantation | 3 | 2023 | 1566 | 0.150 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 3 | 2017 | 920 | 0.150 |
Why?
|
| Opioid-Related Disorders | 3 | 2024 | 2178 | 0.150 |
Why?
|
| Cardiovascular Diseases | 11 | 2018 | 15652 | 0.150 |
Why?
|
| Aortic Aneurysm, Abdominal | 2 | 2022 | 1211 | 0.150 |
Why?
|
| Child, Preschool | 36 | 2023 | 42500 | 0.150 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2002 | 664 | 0.150 |
Why?
|
| Urinary Bladder, Overactive | 1 | 2020 | 117 | 0.150 |
Why?
|
| Health Behavior | 6 | 2025 | 2650 | 0.150 |
Why?
|
| Surgical Sponges | 2 | 2008 | 40 | 0.150 |
Why?
|
| Surgical Flaps | 4 | 2010 | 1677 | 0.150 |
Why?
|
| Health Facilities | 2 | 2020 | 577 | 0.150 |
Why?
|
| Minority Health | 1 | 2019 | 79 | 0.150 |
Why?
|
| Mouth Neoplasms | 1 | 2023 | 594 | 0.150 |
Why?
|
| Academic Medical Centers | 10 | 2023 | 2780 | 0.150 |
Why?
|
| Body Mass Index | 13 | 2022 | 13039 | 0.150 |
Why?
|
| Inservice Training | 3 | 2017 | 375 | 0.150 |
Why?
|
| Kidney Failure, Chronic | 5 | 2017 | 2495 | 0.150 |
Why?
|
| Incidence | 20 | 2023 | 21480 | 0.150 |
Why?
|
| Tetralogy of Fallot | 1 | 2023 | 629 | 0.150 |
Why?
|
| Esophageal Neoplasms | 3 | 2020 | 1661 | 0.150 |
Why?
|
| Child, Hospitalized | 2 | 2017 | 181 | 0.150 |
Why?
|
| Adiposity | 4 | 2013 | 1890 | 0.150 |
Why?
|
| Infant, Newborn | 20 | 2023 | 26346 | 0.150 |
Why?
|
| Phenotype | 3 | 2024 | 16721 | 0.150 |
Why?
|
| Liver Neoplasms | 8 | 2023 | 4353 | 0.150 |
Why?
|
| Patients | 2 | 2016 | 910 | 0.150 |
Why?
|
| Communications Media | 1 | 2018 | 42 | 0.140 |
Why?
|
| Microcomputers | 1 | 2018 | 139 | 0.140 |
Why?
|
| Health Surveys | 7 | 2018 | 4056 | 0.140 |
Why?
|
| Surgical Instruments | 2 | 2012 | 377 | 0.140 |
Why?
|
| Decision Trees | 1 | 2019 | 509 | 0.140 |
Why?
|
| Life Expectancy | 5 | 2019 | 1247 | 0.140 |
Why?
|
| Carcinoma, Renal Cell | 3 | 2019 | 3181 | 0.140 |
Why?
|
| Hospitals, Teaching | 4 | 2017 | 1158 | 0.140 |
Why?
|
| Wound Infection | 1 | 2019 | 244 | 0.140 |
Why?
|
| Cardiomyopathies | 5 | 2012 | 2067 | 0.140 |
Why?
|
| Psychometrics | 4 | 2020 | 3062 | 0.140 |
Why?
|
| Equipment Safety | 2 | 2016 | 250 | 0.140 |
Why?
|
| Professional-Family Relations | 2 | 2018 | 501 | 0.140 |
Why?
|
| Kaplan-Meier Estimate | 10 | 2018 | 6499 | 0.140 |
Why?
|
| Nutrition Surveys | 5 | 2024 | 1741 | 0.140 |
Why?
|
| Appendiceal Neoplasms | 1 | 2019 | 155 | 0.140 |
Why?
|
| Periodontal Diseases | 2 | 2019 | 453 | 0.140 |
Why?
|
| Competency-Based Education | 2 | 2010 | 226 | 0.140 |
Why?
|
| Travel | 1 | 2023 | 806 | 0.140 |
Why?
|
| Physical Exertion | 1 | 2020 | 665 | 0.140 |
Why?
|
| Health Care Reform | 4 | 2019 | 1259 | 0.140 |
Why?
|
| Lung Neoplasms | 6 | 2024 | 13451 | 0.140 |
Why?
|
| Malpractice | 8 | 2007 | 561 | 0.140 |
Why?
|
| Physicians, Family | 2 | 2009 | 349 | 0.130 |
Why?
|
| Feedback | 2 | 2023 | 796 | 0.130 |
Why?
|
| Clinical Clerkship | 3 | 2013 | 568 | 0.130 |
Why?
|
| Diagnostic Tests, Routine | 3 | 2018 | 790 | 0.130 |
Why?
|
| Health Status Disparities | 3 | 2023 | 1880 | 0.130 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2023 | 855 | 0.130 |
Why?
|
| Hospital Units | 1 | 2017 | 142 | 0.130 |
Why?
|
| Sentinel Lymph Node Biopsy | 3 | 2010 | 728 | 0.130 |
Why?
|
| Salvage Therapy | 2 | 2014 | 1272 | 0.130 |
Why?
|
| Surgicenters | 1 | 2016 | 38 | 0.130 |
Why?
|
| Urologic Neoplasms | 2 | 2017 | 310 | 0.130 |
Why?
|
| Buprenorphine | 1 | 2024 | 665 | 0.130 |
Why?
|
| Forecasting | 3 | 2017 | 2936 | 0.130 |
Why?
|
| Meta-Analysis as Topic | 1 | 2001 | 1370 | 0.130 |
Why?
|
| Medical Staff, Hospital | 2 | 2011 | 601 | 0.130 |
Why?
|
| Intestinal Obstruction | 2 | 2018 | 432 | 0.130 |
Why?
|
| Health Communication | 1 | 2019 | 216 | 0.130 |
Why?
|
| Clinical Laboratory Information Systems | 1 | 2017 | 108 | 0.130 |
Why?
|
| Peripheral Vascular Diseases | 2 | 2009 | 516 | 0.130 |
Why?
|
| Health Status Indicators | 3 | 2011 | 966 | 0.130 |
Why?
|
| Midwifery | 1 | 2017 | 132 | 0.130 |
Why?
|
| National Health Insurance, United States | 1 | 2016 | 100 | 0.130 |
Why?
|
| Hypoalbuminemia | 1 | 2016 | 90 | 0.130 |
Why?
|
| Surgical Wound Infection | 5 | 2016 | 1543 | 0.130 |
Why?
|
| Lawyers | 1 | 2016 | 39 | 0.130 |
Why?
|
| Substance-Related Disorders | 3 | 2023 | 4416 | 0.130 |
Why?
|
| Health Resources | 3 | 2013 | 949 | 0.130 |
Why?
|
| Lymphatic Metastasis | 6 | 2019 | 2887 | 0.130 |
Why?
|
| Coronary Disease | 3 | 2005 | 5912 | 0.130 |
Why?
|
| Markov Chains | 2 | 2019 | 968 | 0.130 |
Why?
|
| Postoperative Care | 3 | 2021 | 1470 | 0.130 |
Why?
|
| Nurse-Patient Relations | 1 | 2016 | 102 | 0.120 |
Why?
|
| Wounds, Gunshot | 1 | 2021 | 585 | 0.120 |
Why?
|
| Critical Illness | 6 | 2020 | 2744 | 0.120 |
Why?
|
| Task Performance and Analysis | 3 | 2018 | 770 | 0.120 |
Why?
|
| Medication Adherence | 4 | 2021 | 2192 | 0.120 |
Why?
|
| Diagnosis | 2 | 2024 | 158 | 0.120 |
Why?
|
| Recovery of Function | 7 | 2020 | 2966 | 0.120 |
Why?
|
| Pilot Projects | 11 | 2020 | 8733 | 0.120 |
Why?
|
| Epidemiologic Methods | 4 | 2012 | 1326 | 0.120 |
Why?
|
| Personnel, Hospital | 1 | 2017 | 286 | 0.120 |
Why?
|
| Cross-Cultural Comparison | 1 | 1998 | 634 | 0.120 |
Why?
|
| Sampling Studies | 4 | 2015 | 607 | 0.120 |
Why?
|
| Veterans Health | 1 | 2017 | 216 | 0.120 |
Why?
|
| Pseudomonas Infections | 1 | 2019 | 622 | 0.120 |
Why?
|
| National Health Programs | 1 | 1998 | 443 | 0.120 |
Why?
|
| Carcinoma in Situ | 2 | 2012 | 779 | 0.120 |
Why?
|
| Clinical Protocols | 2 | 2018 | 1441 | 0.120 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2023 | 2247 | 0.120 |
Why?
|
| HIV | 1 | 2002 | 1585 | 0.120 |
Why?
|
| Urothelium | 1 | 2017 | 272 | 0.120 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 2016 | 199 | 0.120 |
Why?
|
| Mutagenicity Tests | 1 | 1994 | 46 | 0.120 |
Why?
|
| Population Density | 1 | 2015 | 193 | 0.120 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2017 | 258 | 0.120 |
Why?
|
| Oxytocics | 1 | 2015 | 67 | 0.120 |
Why?
|
| Controlled Clinical Trials as Topic | 2 | 2009 | 187 | 0.120 |
Why?
|
| Income | 7 | 2025 | 1874 | 0.120 |
Why?
|
| Reminder Systems | 1 | 2018 | 388 | 0.120 |
Why?
|
| Endpoint Determination | 1 | 2017 | 591 | 0.120 |
Why?
|
| Heart Arrest | 3 | 2021 | 1516 | 0.120 |
Why?
|
| Marital Status | 1 | 2016 | 426 | 0.120 |
Why?
|
| Emergency Service, Hospital | 6 | 2021 | 7875 | 0.120 |
Why?
|
| Health Services Needs and Demand | 3 | 2019 | 1406 | 0.120 |
Why?
|
| Office Visits | 2 | 2016 | 595 | 0.120 |
Why?
|
| Tachycardia, Ventricular | 1 | 2023 | 1310 | 0.120 |
Why?
|
| Goals | 2 | 2019 | 719 | 0.110 |
Why?
|
| Pregnancy | 16 | 2024 | 30260 | 0.110 |
Why?
|
| Ghana | 3 | 2020 | 333 | 0.110 |
Why?
|
| Medical Records | 4 | 2012 | 1409 | 0.110 |
Why?
|
| Cardiovascular Agents | 4 | 2010 | 851 | 0.110 |
Why?
|
| Health Benefit Plans, Employee | 1 | 2017 | 331 | 0.110 |
Why?
|
| Unnecessary Procedures | 3 | 2017 | 416 | 0.110 |
Why?
|
| Health Status | 5 | 2018 | 4080 | 0.110 |
Why?
|
| Postpartum Period | 2 | 2018 | 1205 | 0.110 |
Why?
|
| Endovascular Procedures | 2 | 2022 | 2222 | 0.110 |
Why?
|
| Pneumonia | 4 | 2020 | 2157 | 0.110 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 2 | 2007 | 416 | 0.110 |
Why?
|
| Managed Care Programs | 1 | 2019 | 934 | 0.110 |
Why?
|
| Nursing Services | 1 | 2013 | 6 | 0.110 |
Why?
|
| Terminally Ill | 1 | 2016 | 241 | 0.110 |
Why?
|
| Traumatology | 1 | 2015 | 102 | 0.110 |
Why?
|
| Infant Mortality | 2 | 2016 | 751 | 0.110 |
Why?
|
| Coronary Artery Bypass | 3 | 2019 | 2186 | 0.110 |
Why?
|
| Insurance Benefits | 1 | 2016 | 186 | 0.110 |
Why?
|
| Guidelines as Topic | 3 | 2017 | 1394 | 0.110 |
Why?
|
| Biomedical Technology | 1 | 2016 | 210 | 0.110 |
Why?
|
| Disease-Free Survival | 10 | 2013 | 6832 | 0.110 |
Why?
|
| Case-Control Studies | 9 | 2024 | 22223 | 0.110 |
Why?
|
| Digestive System Surgical Procedures | 2 | 2016 | 580 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 7 | 2024 | 7425 | 0.110 |
Why?
|
| Child Health Services | 3 | 2013 | 645 | 0.110 |
Why?
|
| Foreign Bodies | 2 | 2008 | 402 | 0.110 |
Why?
|
| Smoking | 9 | 2024 | 9081 | 0.110 |
Why?
|
| Computers | 1 | 2016 | 588 | 0.110 |
Why?
|
| Toxicology | 1 | 1994 | 102 | 0.110 |
Why?
|
| Health Promotion | 3 | 2018 | 2208 | 0.110 |
Why?
|
| Cost Savings | 4 | 2023 | 904 | 0.110 |
Why?
|
| Colonic Neoplasms | 2 | 2024 | 2531 | 0.110 |
Why?
|
| Education, Medical | 2 | 2017 | 1746 | 0.110 |
Why?
|
| Vaginal Smears | 2 | 2021 | 513 | 0.110 |
Why?
|
| Computational Biology | 2 | 2005 | 3559 | 0.110 |
Why?
|
| Infant | 25 | 2023 | 36386 | 0.110 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2015 | 236 | 0.110 |
Why?
|
| Siblings | 3 | 2013 | 828 | 0.110 |
Why?
|
| Ethics, Medical | 1 | 1998 | 783 | 0.110 |
Why?
|
| Ventricular Dysfunction, Left | 4 | 2024 | 2136 | 0.110 |
Why?
|
| Problem-Based Learning | 1 | 2017 | 360 | 0.110 |
Why?
|
| Directive Counseling | 1 | 2014 | 171 | 0.110 |
Why?
|
| Certificate of Need | 1 | 2012 | 10 | 0.100 |
Why?
|
| Air Pollution | 6 | 1996 | 2380 | 0.100 |
Why?
|
| Nursing Care | 1 | 2013 | 68 | 0.100 |
Why?
|
| Intention | 1 | 2016 | 346 | 0.100 |
Why?
|
| Respiration, Artificial | 2 | 2023 | 2709 | 0.100 |
Why?
|
| Leg | 2 | 2009 | 1080 | 0.100 |
Why?
|
| Muscle, Smooth | 1 | 2017 | 931 | 0.100 |
Why?
|
| Alzheimer Disease | 3 | 2024 | 8730 | 0.100 |
Why?
|
| Mammography | 6 | 2021 | 2423 | 0.100 |
Why?
|
| Heart Ventricles | 5 | 2024 | 3832 | 0.100 |
Why?
|
| Antineoplastic Agents | 11 | 2016 | 13648 | 0.100 |
Why?
|
| Florida | 3 | 2018 | 416 | 0.100 |
Why?
|
| Spinal Fusion | 2 | 2019 | 1302 | 0.100 |
Why?
|
| Capacity Building | 1 | 2015 | 266 | 0.100 |
Why?
|
| Neoplasm Metastasis | 6 | 2023 | 4893 | 0.100 |
Why?
|
| Blood Transfusion | 6 | 2017 | 1297 | 0.100 |
Why?
|
| Referral and Consultation | 3 | 2023 | 3615 | 0.100 |
Why?
|
| Memory, Short-Term | 1 | 2019 | 1003 | 0.100 |
Why?
|
| Muscle Tonus | 1 | 2012 | 82 | 0.100 |
Why?
|
| Vocabulary, Controlled | 1 | 2013 | 172 | 0.100 |
Why?
|
| Hospitals, Military | 3 | 2017 | 62 | 0.100 |
Why?
|
| Matched-Pair Analysis | 2 | 2003 | 284 | 0.100 |
Why?
|
| Burnout, Professional | 1 | 2021 | 711 | 0.100 |
Why?
|
| Surgical Stomas | 1 | 2012 | 45 | 0.100 |
Why?
|
| Testicular Neoplasms | 1 | 2018 | 786 | 0.100 |
Why?
|
| Triage | 1 | 2019 | 996 | 0.100 |
Why?
|
| Internationality | 3 | 2016 | 1007 | 0.100 |
Why?
|
| Hospital Administrators | 1 | 2012 | 57 | 0.100 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2024 | 1480 | 0.100 |
Why?
|
| Personnel Selection | 1 | 2014 | 201 | 0.100 |
Why?
|
| Manikins | 1 | 2014 | 251 | 0.100 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2018 | 1133 | 0.100 |
Why?
|
| Hormone Replacement Therapy | 1 | 2018 | 753 | 0.100 |
Why?
|
| Ventricular Remodeling | 3 | 2023 | 1272 | 0.100 |
Why?
|
| Health Services | 1 | 2017 | 756 | 0.100 |
Why?
|
| Comprehension | 2 | 2024 | 638 | 0.100 |
Why?
|
| Insurance Carriers | 1 | 2014 | 159 | 0.100 |
Why?
|
| Smoking Cessation | 1 | 2024 | 2084 | 0.100 |
Why?
|
| Pneumonectomy | 2 | 2017 | 1128 | 0.100 |
Why?
|
| Hemochromatosis | 1 | 2013 | 175 | 0.100 |
Why?
|
| Professional Competence | 1 | 2015 | 429 | 0.100 |
Why?
|
| Endarterectomy, Carotid | 1 | 2017 | 557 | 0.100 |
Why?
|
| Internet | 2 | 2016 | 3106 | 0.090 |
Why?
|
| Acute Kidney Injury | 2 | 2021 | 1946 | 0.090 |
Why?
|
| Caregivers | 2 | 2023 | 2307 | 0.090 |
Why?
|
| Depression | 3 | 2023 | 8237 | 0.090 |
Why?
|
| Data Collection | 6 | 2011 | 3318 | 0.090 |
Why?
|
| Postpartum Hemorrhage | 1 | 2015 | 276 | 0.090 |
Why?
|
| Thromboembolism | 1 | 2018 | 1003 | 0.090 |
Why?
|
| Interprofessional Relations | 3 | 2015 | 999 | 0.090 |
Why?
|
| Veins | 3 | 2010 | 764 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2024 | 36532 | 0.090 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2019 | 1534 | 0.090 |
Why?
|
| Anal Canal | 1 | 2014 | 376 | 0.090 |
Why?
|
| Neoplasm Recurrence, Local | 8 | 2017 | 9373 | 0.090 |
Why?
|
| Thyroid Neoplasms | 3 | 2022 | 2371 | 0.090 |
Why?
|
| Geographic Information Systems | 2 | 2020 | 280 | 0.090 |
Why?
|
| Patient Selection | 3 | 2020 | 4255 | 0.090 |
Why?
|
| Oxytocin | 1 | 2015 | 404 | 0.090 |
Why?
|
| Health Care Coalitions | 1 | 2011 | 36 | 0.090 |
Why?
|
| Economic Competition | 1 | 2013 | 223 | 0.090 |
Why?
|
| Intraoperative Care | 3 | 2012 | 760 | 0.090 |
Why?
|
| Facial Transplantation | 1 | 2013 | 221 | 0.090 |
Why?
|
| Anticoagulants | 2 | 2024 | 4862 | 0.090 |
Why?
|
| Pregnancy Complications | 2 | 2016 | 2975 | 0.090 |
Why?
|
| Sutures | 2 | 2010 | 284 | 0.090 |
Why?
|
| Cause of Death | 5 | 2016 | 3708 | 0.090 |
Why?
|
| Staphylococcal Infections | 1 | 2019 | 1393 | 0.090 |
Why?
|
| Health Services Research | 3 | 2019 | 1808 | 0.090 |
Why?
|
| Fluorouracil | 8 | 2005 | 1648 | 0.090 |
Why?
|
| Surgical Mesh | 2 | 2010 | 315 | 0.090 |
Why?
|
| Pancreatic Neoplasms | 5 | 2018 | 5444 | 0.090 |
Why?
|
| Culture | 1 | 2014 | 622 | 0.090 |
Why?
|
| Androgens | 1 | 2018 | 1279 | 0.090 |
Why?
|
| Self Efficacy | 2 | 2014 | 642 | 0.090 |
Why?
|
| Resuscitation | 1 | 2015 | 679 | 0.090 |
Why?
|
| Polyglactin 910 | 1 | 2010 | 56 | 0.090 |
Why?
|
| Genetic Testing | 1 | 2023 | 3595 | 0.090 |
Why?
|
| Axilla | 2 | 2010 | 615 | 0.090 |
Why?
|
| Physician's Role | 1 | 2017 | 927 | 0.090 |
Why?
|
| Mathematical Computing | 1 | 1990 | 143 | 0.090 |
Why?
|
| Renal Artery | 1 | 2012 | 345 | 0.090 |
Why?
|
| Work Schedule Tolerance | 2 | 2016 | 555 | 0.090 |
Why?
|
| Rectus Abdominis | 1 | 2010 | 101 | 0.080 |
Why?
|
| Feasibility Studies | 6 | 2023 | 5302 | 0.080 |
Why?
|
| Heart Failure | 6 | 2020 | 11840 | 0.080 |
Why?
|
| Models, Theoretical | 3 | 2016 | 3564 | 0.080 |
Why?
|
| Pregnancy Outcome | 2 | 2019 | 2966 | 0.080 |
Why?
|
| Patient Access to Records | 1 | 2011 | 120 | 0.080 |
Why?
|
| Patient Identification Systems | 1 | 2010 | 75 | 0.080 |
Why?
|
| Cranial Irradiation | 1 | 2012 | 385 | 0.080 |
Why?
|
| Carotid Stenosis | 1 | 2017 | 861 | 0.080 |
Why?
|
| Canada | 4 | 2019 | 2119 | 0.080 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 2659 | 0.080 |
Why?
|
| Colposcopy | 1 | 2010 | 151 | 0.080 |
Why?
|
| Fluvoxamine | 2 | 1999 | 77 | 0.080 |
Why?
|
| Endocrine System Diseases | 1 | 2012 | 243 | 0.080 |
Why?
|
| Hospitals, Urban | 2 | 2010 | 493 | 0.080 |
Why?
|
| Breast Self-Examination | 1 | 2009 | 33 | 0.080 |
Why?
|
| Health Services for the Aged | 1 | 2012 | 265 | 0.080 |
Why?
|
| New Jersey | 1 | 2010 | 296 | 0.080 |
Why?
|
| Narcotics | 1 | 2011 | 332 | 0.080 |
Why?
|
| Headache | 2 | 2021 | 1259 | 0.080 |
Why?
|
| Ethylene Glycol | 1 | 2009 | 31 | 0.080 |
Why?
|
| Phlebotomy | 1 | 2010 | 138 | 0.080 |
Why?
|
| Alcohol Drinking | 1 | 2022 | 4040 | 0.080 |
Why?
|
| Family | 5 | 2020 | 3209 | 0.080 |
Why?
|
| Evidence-Based Medicine | 5 | 2018 | 3685 | 0.080 |
Why?
|
| Abdomen | 1 | 2015 | 1134 | 0.080 |
Why?
|
| Radiotherapy, Intensity-Modulated | 2 | 2012 | 784 | 0.080 |
Why?
|
| Hospital Bed Capacity | 1 | 2010 | 200 | 0.080 |
Why?
|
| Cervical Vertebrae | 1 | 2015 | 974 | 0.080 |
Why?
|
| Hospitals, General | 3 | 2023 | 802 | 0.080 |
Why?
|
| Myocardial Contraction | 5 | 2024 | 1515 | 0.080 |
Why?
|
| Clinical Pharmacy Information Systems | 1 | 2009 | 102 | 0.080 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 2 | 2012 | 1145 | 0.080 |
Why?
|
| Case Management | 1 | 2011 | 277 | 0.080 |
Why?
|
| Insurance, Health | 2 | 2019 | 2521 | 0.080 |
Why?
|
| Spinal Fractures | 1 | 2015 | 703 | 0.080 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2010 | 213 | 0.080 |
Why?
|
| Cardiotonic Agents | 1 | 2012 | 538 | 0.080 |
Why?
|
| Cooperative Behavior | 1 | 2016 | 1509 | 0.080 |
Why?
|
| Specialization | 1 | 2013 | 777 | 0.080 |
Why?
|
| Body Water | 1 | 2010 | 338 | 0.080 |
Why?
|
| Random Allocation | 4 | 2022 | 2395 | 0.080 |
Why?
|
| Myocardial Infarction | 5 | 2020 | 11499 | 0.080 |
Why?
|
| Activities of Daily Living | 1 | 2018 | 2415 | 0.080 |
Why?
|
| Suture Techniques | 2 | 2010 | 773 | 0.080 |
Why?
|
| Risk Adjustment | 3 | 2017 | 596 | 0.080 |
Why?
|
| Carcinoma | 2 | 2011 | 2312 | 0.080 |
Why?
|
| Emotions | 2 | 2011 | 2763 | 0.080 |
Why?
|
| Interdisciplinary Communication | 2 | 2011 | 932 | 0.080 |
Why?
|
| Mass Screening | 7 | 2021 | 5446 | 0.080 |
Why?
|
| Fees, Pharmaceutical | 1 | 2008 | 66 | 0.080 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2007 | 1936 | 0.070 |
Why?
|
| Physical Fitness | 1 | 2012 | 742 | 0.070 |
Why?
|
| Prognosis | 13 | 2018 | 29922 | 0.070 |
Why?
|
| Hodgkin Disease | 2 | 2007 | 1383 | 0.070 |
Why?
|
| Prescription Drugs | 2 | 2019 | 634 | 0.070 |
Why?
|
| Burns | 1 | 2019 | 1903 | 0.070 |
Why?
|
| Poverty | 4 | 2023 | 2714 | 0.070 |
Why?
|
| Faculty, Medical | 3 | 2011 | 1219 | 0.070 |
Why?
|
| Models, Biological | 5 | 2010 | 9443 | 0.070 |
Why?
|
| Device Approval | 1 | 2009 | 164 | 0.070 |
Why?
|
| Medical Informatics Applications | 1 | 2009 | 180 | 0.070 |
Why?
|
| Pelvis | 3 | 2019 | 738 | 0.070 |
Why?
|
| Cost-Benefit Analysis | 6 | 2023 | 5526 | 0.070 |
Why?
|
| Costs and Cost Analysis | 4 | 2015 | 1668 | 0.070 |
Why?
|
| Receptor, Bradykinin B2 | 1 | 2007 | 25 | 0.070 |
Why?
|
| Self Report | 3 | 2018 | 3770 | 0.070 |
Why?
|
| Morbidity | 5 | 2017 | 1749 | 0.070 |
Why?
|
| Tobacco Smoke Pollution | 5 | 2006 | 827 | 0.070 |
Why?
|
| Asthma | 3 | 2004 | 6270 | 0.070 |
Why?
|
| Lymph Nodes | 3 | 2017 | 3454 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2021 | 20659 | 0.070 |
Why?
|
| Consumer Health Information | 1 | 2010 | 215 | 0.070 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2009 | 265 | 0.070 |
Why?
|
| Arthroplasty | 1 | 2010 | 306 | 0.070 |
Why?
|
| Mortality | 4 | 2024 | 2904 | 0.070 |
Why?
|
| Face | 1 | 2013 | 1028 | 0.070 |
Why?
|
| Nursing Staff, Hospital | 1 | 2010 | 350 | 0.070 |
Why?
|
| Cross Infection | 3 | 2014 | 1427 | 0.070 |
Why?
|
| Asia | 3 | 2015 | 628 | 0.070 |
Why?
|
| Orthopedics | 1 | 2016 | 900 | 0.070 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2021 | 5389 | 0.070 |
Why?
|
| Troponin I | 3 | 2008 | 655 | 0.070 |
Why?
|
| Troponin | 2 | 2003 | 533 | 0.070 |
Why?
|
| Diagnostic Imaging | 2 | 2011 | 3529 | 0.070 |
Why?
|
| Testosterone | 1 | 2018 | 2494 | 0.070 |
Why?
|
| Paintings | 1 | 2008 | 101 | 0.070 |
Why?
|
| Israel | 3 | 2016 | 725 | 0.070 |
Why?
|
| Denmark | 3 | 2016 | 774 | 0.070 |
Why?
|
| Interferon-alpha | 3 | 2002 | 910 | 0.070 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2011 | 374 | 0.070 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2011 | 349 | 0.070 |
Why?
|
| Emergency Medicine | 1 | 2016 | 1221 | 0.070 |
Why?
|
| Communication Barriers | 2 | 2024 | 418 | 0.070 |
Why?
|
| Hernia, Ventral | 1 | 2010 | 220 | 0.070 |
Why?
|
| Multicenter Studies as Topic | 3 | 2021 | 1731 | 0.070 |
Why?
|
| Blood Loss, Surgical | 4 | 2012 | 629 | 0.070 |
Why?
|
| Observation | 1 | 2008 | 309 | 0.070 |
Why?
|
| Antimetabolites, Antineoplastic | 3 | 2002 | 647 | 0.070 |
Why?
|
| Natriuretic Peptide, Brain | 2 | 2012 | 1736 | 0.070 |
Why?
|
| Treatment Failure | 5 | 2015 | 2652 | 0.070 |
Why?
|
| Prevalence | 7 | 2023 | 15842 | 0.070 |
Why?
|
| Germany | 2 | 2018 | 882 | 0.070 |
Why?
|
| Oxygen Consumption | 1 | 2012 | 1870 | 0.060 |
Why?
|
| Vitamin K | 1 | 2008 | 312 | 0.060 |
Why?
|
| Didanosine | 2 | 2010 | 151 | 0.060 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 2010 | 2203 | 0.060 |
Why?
|
| Auranofin | 3 | 1999 | 16 | 0.060 |
Why?
|
| Diet | 4 | 2013 | 8086 | 0.060 |
Why?
|
| Catheterization, Peripheral | 1 | 2009 | 349 | 0.060 |
Why?
|
| Back Pain | 1 | 2010 | 544 | 0.060 |
Why?
|
| Head | 1 | 2012 | 925 | 0.060 |
Why?
|
| Cryosurgery | 1 | 2011 | 479 | 0.060 |
Why?
|
| Accidents, Traffic | 2 | 2021 | 818 | 0.060 |
Why?
|
| Insurance Claim Review | 3 | 2019 | 746 | 0.060 |
Why?
|
| Tunica Media | 1 | 2006 | 107 | 0.060 |
Why?
|
| Intestinal Diseases | 1 | 2010 | 506 | 0.060 |
Why?
|
| Limb Salvage | 1 | 2008 | 488 | 0.060 |
Why?
|
| Bioprosthesis | 1 | 2010 | 589 | 0.060 |
Why?
|
| Job Satisfaction | 1 | 2009 | 549 | 0.060 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2010 | 504 | 0.060 |
Why?
|
| New York | 6 | 2020 | 880 | 0.060 |
Why?
|
| Emergency Medical Services | 3 | 2012 | 1938 | 0.060 |
Why?
|
| Nurse Practitioners | 2 | 2024 | 272 | 0.060 |
Why?
|
| Diagnosis-Related Groups | 2 | 2019 | 445 | 0.060 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2009 | 729 | 0.060 |
Why?
|
| Stents | 1 | 2017 | 3213 | 0.060 |
Why?
|
| Teaching | 1 | 2013 | 1169 | 0.060 |
Why?
|
| Severity of Illness Index | 6 | 2020 | 15880 | 0.060 |
Why?
|
| Energy Intake | 1 | 2013 | 2141 | 0.060 |
Why?
|
| Neurosurgical Procedures | 2 | 2020 | 2074 | 0.060 |
Why?
|
| Disease | 1 | 2010 | 676 | 0.060 |
Why?
|
| Sensitivity and Specificity | 9 | 2015 | 14652 | 0.060 |
Why?
|
| Angioplasty | 1 | 2007 | 352 | 0.060 |
Why?
|
| Patient Preference | 2 | 2024 | 952 | 0.060 |
Why?
|
| Cognition | 2 | 2023 | 7049 | 0.060 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2018 | 1896 | 0.060 |
Why?
|
| Melanoma | 2 | 2019 | 5719 | 0.060 |
Why?
|
| Rural Health Services | 2 | 2019 | 393 | 0.060 |
Why?
|
| Workflow | 3 | 2016 | 862 | 0.060 |
Why?
|
| Heart Valve Diseases | 2 | 2010 | 1030 | 0.060 |
Why?
|
| Demography | 3 | 2018 | 1641 | 0.060 |
Why?
|
| Enalapril | 2 | 2005 | 317 | 0.060 |
Why?
|
| Arsenic | 2 | 1998 | 356 | 0.060 |
Why?
|
| Urologic Surgical Procedures, Male | 1 | 2024 | 78 | 0.060 |
Why?
|
| Workplace | 1 | 2011 | 873 | 0.060 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2008 | 521 | 0.060 |
Why?
|
| Body Composition | 2 | 2013 | 2439 | 0.060 |
Why?
|
| Schizophrenia | 2 | 2011 | 6972 | 0.060 |
Why?
|
| Rural Health | 1 | 2006 | 301 | 0.060 |
Why?
|
| Streptozocin | 3 | 2007 | 189 | 0.060 |
Why?
|
| Perioperative Care | 2 | 2024 | 1055 | 0.060 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2007 | 540 | 0.060 |
Why?
|
| Chest Pain | 2 | 2021 | 1100 | 0.060 |
Why?
|
| Chronic Disease | 2 | 2017 | 9347 | 0.060 |
Why?
|
| Zidovudine | 2 | 2010 | 626 | 0.060 |
Why?
|
| Hospitals, University | 4 | 2009 | 574 | 0.060 |
Why?
|
| Caffeine | 1 | 2008 | 702 | 0.060 |
Why?
|
| Water Pollutants, Chemical | 2 | 1998 | 358 | 0.060 |
Why?
|
| Informed Consent | 1 | 2010 | 1010 | 0.060 |
Why?
|
| Evidence-Based Practice | 2 | 2020 | 500 | 0.060 |
Why?
|
| Hemoglobins | 3 | 2011 | 1530 | 0.060 |
Why?
|
| Ubiquinone | 1 | 2005 | 181 | 0.050 |
Why?
|
| Tunica Intima | 1 | 2006 | 455 | 0.050 |
Why?
|
| Carcinoid Tumor | 1 | 2005 | 225 | 0.050 |
Why?
|
| Thoracic Surgery | 1 | 2010 | 728 | 0.050 |
Why?
|
| Amputees | 1 | 2024 | 101 | 0.050 |
Why?
|
| Mathematics | 2 | 1995 | 696 | 0.050 |
Why?
|
| Control Groups | 1 | 2023 | 106 | 0.050 |
Why?
|
| Risk Management | 1 | 2007 | 559 | 0.050 |
Why?
|
| Tricuspid Valve | 1 | 2006 | 422 | 0.050 |
Why?
|
| Respiratory-Gated Imaging Techniques | 1 | 2024 | 73 | 0.050 |
Why?
|
| Medicare Part D | 1 | 2008 | 355 | 0.050 |
Why?
|
| Physicians, Women | 1 | 2009 | 512 | 0.050 |
Why?
|
| Hyperglycemia | 2 | 2010 | 1393 | 0.050 |
Why?
|
| Learning | 1 | 2013 | 1755 | 0.050 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2008 | 747 | 0.050 |
Why?
|
| Diabetic Foot | 1 | 2007 | 384 | 0.050 |
Why?
|
| Cholesterol | 3 | 2012 | 2898 | 0.050 |
Why?
|
| Carotid Artery, Internal | 1 | 2006 | 437 | 0.050 |
Why?
|
| Audiovisual Aids | 1 | 2024 | 98 | 0.050 |
Why?
|
| Health Literacy | 2 | 2024 | 464 | 0.050 |
Why?
|
| Polymers | 1 | 2010 | 1621 | 0.050 |
Why?
|
| Educational Status | 4 | 2016 | 2513 | 0.050 |
Why?
|
| Liver Cirrhosis, Biliary | 2 | 2005 | 107 | 0.050 |
Why?
|
| Mediastinum | 1 | 2004 | 271 | 0.050 |
Why?
|
| Cystatin C | 1 | 2024 | 272 | 0.050 |
Why?
|
| Sleep Deprivation | 1 | 2009 | 845 | 0.050 |
Why?
|
| Clostridium Infections | 1 | 2009 | 564 | 0.050 |
Why?
|
| Ambulatory Care Facilities | 2 | 2023 | 939 | 0.050 |
Why?
|
| Vitamin A | 3 | 1996 | 610 | 0.050 |
Why?
|
| Isoenzymes | 3 | 2003 | 1689 | 0.050 |
Why?
|
| Peptide Fragments | 2 | 2012 | 5125 | 0.050 |
Why?
|
| Space Simulation | 1 | 2022 | 9 | 0.050 |
Why?
|
| User-Computer Interface | 2 | 2019 | 1405 | 0.050 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 2022 | 158 | 0.050 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2006 | 363 | 0.050 |
Why?
|
| Uncertainty | 1 | 2007 | 761 | 0.050 |
Why?
|
| Infection Control | 1 | 2009 | 983 | 0.050 |
Why?
|
| Lung | 4 | 2024 | 10033 | 0.050 |
Why?
|
| Blood Cell Count | 1 | 2023 | 405 | 0.050 |
Why?
|
| Myocytes, Cardiac | 2 | 2008 | 1668 | 0.050 |
Why?
|
| Uremia | 1 | 2003 | 202 | 0.050 |
Why?
|
| Physical Examination | 1 | 2008 | 1266 | 0.050 |
Why?
|
| Parturition | 2 | 2018 | 454 | 0.050 |
Why?
|
| Anus Neoplasms | 2 | 1996 | 336 | 0.050 |
Why?
|
| Evaluation Studies as Topic | 3 | 2008 | 1600 | 0.050 |
Why?
|
| Africa | 2 | 2015 | 725 | 0.050 |
Why?
|
| Colonoscopy | 2 | 2021 | 1406 | 0.050 |
Why?
|
| Personal Autonomy | 1 | 2024 | 315 | 0.050 |
Why?
|
| Mothers | 4 | 2006 | 2210 | 0.050 |
Why?
|
| Observer Variation | 2 | 2020 | 2615 | 0.050 |
Why?
|
| Information Dissemination | 1 | 2010 | 1142 | 0.050 |
Why?
|
| Organizational Case Studies | 2 | 2014 | 299 | 0.050 |
Why?
|
| Reoperation | 5 | 2010 | 4294 | 0.050 |
Why?
|
| Geriatric Assessment | 2 | 2020 | 1429 | 0.050 |
Why?
|
| Social Support | 1 | 2011 | 2192 | 0.050 |
Why?
|
| Biocompatible Materials | 1 | 2010 | 1682 | 0.050 |
Why?
|
| Heart Valve Prosthesis | 1 | 2010 | 1466 | 0.050 |
Why?
|
| Penile Erection | 2 | 2012 | 100 | 0.050 |
Why?
|
| Creatine Kinase, MB Form | 3 | 2008 | 202 | 0.050 |
Why?
|
| Cachexia | 1 | 2023 | 200 | 0.050 |
Why?
|
| HIV Infections | 4 | 2015 | 17533 | 0.050 |
Why?
|
| Tenascin | 1 | 2001 | 61 | 0.050 |
Why?
|
| Stomach Diseases | 1 | 2002 | 134 | 0.050 |
Why?
|
| Lipoproteins | 1 | 2006 | 866 | 0.050 |
Why?
|
| Drug Administration Schedule | 5 | 2012 | 4850 | 0.050 |
Why?
|
| Safety | 3 | 2014 | 1157 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 7478 | 0.050 |
Why?
|
| Evidence-Based Nursing | 1 | 2020 | 12 | 0.050 |
Why?
|
| Ovarian Neoplasms | 1 | 2018 | 4900 | 0.050 |
Why?
|
| Perineum | 2 | 2014 | 213 | 0.050 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2007 | 1118 | 0.050 |
Why?
|
| Diabetic Angiopathies | 1 | 2006 | 805 | 0.040 |
Why?
|
| Fatty Acids | 1 | 2008 | 1806 | 0.040 |
Why?
|
| Standard of Care | 2 | 2017 | 567 | 0.040 |
Why?
|
| Cost of Illness | 2 | 2023 | 1950 | 0.040 |
Why?
|
| Adaptation, Psychological | 1 | 2011 | 2660 | 0.040 |
Why?
|
| Ablation Techniques | 1 | 2023 | 254 | 0.040 |
Why?
|
| Utah | 2 | 2016 | 130 | 0.040 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2005 | 537 | 0.040 |
Why?
|
| North America | 2 | 2018 | 1285 | 0.040 |
Why?
|
| Cholesterol, HDL | 2 | 2006 | 1811 | 0.040 |
Why?
|
| Disease Management | 2 | 2024 | 2535 | 0.040 |
Why?
|
| Environment Design | 1 | 2022 | 174 | 0.040 |
Why?
|
| California | 1 | 2024 | 1436 | 0.040 |
Why?
|
| Heart Transplantation | 3 | 2024 | 3310 | 0.040 |
Why?
|
| Diabetic Nephropathies | 1 | 2007 | 969 | 0.040 |
Why?
|
| Human Growth Hormone | 1 | 2005 | 638 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2013 | 4034 | 0.040 |
Why?
|
| Aortic Valve | 1 | 2010 | 1968 | 0.040 |
Why?
|
| Anti-HIV Agents | 2 | 2010 | 4559 | 0.040 |
Why?
|
| Cholesterol, LDL | 3 | 2006 | 2393 | 0.040 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2023 | 469 | 0.040 |
Why?
|
| Constriction, Pathologic | 1 | 2023 | 1105 | 0.040 |
Why?
|
| Trimetrexate | 1 | 1999 | 15 | 0.040 |
Why?
|
| American Cancer Society | 1 | 2019 | 69 | 0.040 |
Why?
|
| Heart-Assist Devices | 1 | 2010 | 1296 | 0.040 |
Why?
|
| Disulfiram | 1 | 2020 | 63 | 0.040 |
Why?
|
| Topotecan | 1 | 2000 | 130 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2007 | 2666 | 0.040 |
Why?
|
| Germ Cells | 1 | 2023 | 647 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2005 | 1514 | 0.040 |
Why?
|
| Smoke Inhalation Injury | 1 | 2019 | 47 | 0.040 |
Why?
|
| Urination Disorders | 2 | 2011 | 236 | 0.040 |
Why?
|
| Needs Assessment | 2 | 2018 | 1138 | 0.040 |
Why?
|
| Neoplasms, Second Primary | 1 | 2007 | 1050 | 0.040 |
Why?
|
| Albumins | 1 | 2022 | 577 | 0.040 |
Why?
|
| Narcotic Antagonists | 1 | 2024 | 590 | 0.040 |
Why?
|
| Harringtonines | 1 | 1999 | 8 | 0.040 |
Why?
|
| Cholinergic Antagonists | 1 | 2020 | 165 | 0.040 |
Why?
|
| Ventricular Function, Right | 1 | 2023 | 629 | 0.040 |
Why?
|
| Serum Albumin | 2 | 2016 | 675 | 0.040 |
Why?
|
| Single-Blind Method | 2 | 2014 | 1589 | 0.040 |
Why?
|
| Birth Certificates | 1 | 2019 | 71 | 0.040 |
Why?
|
| Scotland | 1 | 2019 | 115 | 0.040 |
Why?
|
| Liver Cirrhosis | 1 | 2009 | 1959 | 0.040 |
Why?
|
| Language | 2 | 2024 | 1550 | 0.040 |
Why?
|
| Technology | 1 | 2021 | 297 | 0.040 |
Why?
|
| Birth Weight | 2 | 2023 | 2121 | 0.040 |
Why?
|
| Gait | 1 | 2024 | 820 | 0.040 |
Why?
|
| Helicobacter pylori | 1 | 2002 | 380 | 0.040 |
Why?
|
| C-Reactive Protein | 4 | 2012 | 3850 | 0.040 |
Why?
|
| Helicobacter Infections | 1 | 2002 | 390 | 0.040 |
Why?
|
| Personal Satisfaction | 1 | 2023 | 641 | 0.040 |
Why?
|
| Gentamicins | 1 | 2019 | 244 | 0.040 |
Why?
|
| Fresh Water | 1 | 1998 | 82 | 0.040 |
Why?
|
| Stomach Neoplasms | 2 | 1999 | 1471 | 0.040 |
Why?
|
| Health Policy | 1 | 2011 | 2698 | 0.040 |
Why?
|
| Advisory Committees | 1 | 2023 | 796 | 0.040 |
Why?
|
| Minocycline | 1 | 2019 | 168 | 0.040 |
Why?
|
| Philosophy, Medical | 1 | 1998 | 78 | 0.040 |
Why?
|
| Iatrogenic Disease | 2 | 1992 | 553 | 0.040 |
Why?
|
| Histological Techniques | 1 | 2019 | 193 | 0.040 |
Why?
|
| Acinetobacter baumannii | 1 | 2019 | 125 | 0.040 |
Why?
|
| Obesity | 4 | 2022 | 13076 | 0.040 |
Why?
|
| Clavicle | 1 | 2020 | 224 | 0.040 |
Why?
|
| gamma-Globulins | 1 | 1998 | 119 | 0.040 |
Why?
|
| Alginates | 1 | 2019 | 247 | 0.040 |
Why?
|
| Faculty | 1 | 2021 | 384 | 0.040 |
Why?
|
| Esophagoscopy | 1 | 2020 | 398 | 0.040 |
Why?
|
| Primary Nursing | 1 | 2017 | 10 | 0.040 |
Why?
|
| Rural Population | 4 | 2017 | 2317 | 0.040 |
Why?
|
| Eye Injuries, Penetrating | 1 | 2019 | 121 | 0.040 |
Why?
|
| Mental Health Services | 2 | 2019 | 1723 | 0.040 |
Why?
|
| Catheter Ablation | 1 | 2011 | 2788 | 0.040 |
Why?
|
| Motivation | 2 | 2022 | 2018 | 0.040 |
Why?
|
| Men's Health | 1 | 2018 | 75 | 0.040 |
Why?
|
| Interviews as Topic | 2 | 2017 | 2739 | 0.040 |
Why?
|
| Hydroxyurea | 1 | 1999 | 284 | 0.040 |
Why?
|
| Jaundice | 1 | 1998 | 94 | 0.040 |
Why?
|
| Respiration | 1 | 2024 | 1653 | 0.040 |
Why?
|
| Intestinal Neoplasms | 2 | 2010 | 313 | 0.040 |
Why?
|
| Aging | 1 | 2016 | 8731 | 0.040 |
Why?
|
| Scleroderma, Systemic | 1 | 2001 | 346 | 0.030 |
Why?
|
| Models, Economic | 2 | 2012 | 716 | 0.030 |
Why?
|
| Equipment Design | 2 | 2019 | 3481 | 0.030 |
Why?
|
| Organizational Innovation | 2 | 2011 | 541 | 0.030 |
Why?
|
| Creatine Kinase | 3 | 2006 | 682 | 0.030 |
Why?
|
| Walking | 1 | 2024 | 1198 | 0.030 |
Why?
|
| Blood Urea Nitrogen | 2 | 2010 | 189 | 0.030 |
Why?
|
| Poisons | 1 | 1997 | 37 | 0.030 |
Why?
|
| Myoglobin | 2 | 2008 | 157 | 0.030 |
Why?
|
| Subacute Care | 1 | 2019 | 184 | 0.030 |
Why?
|
| Antigens, Bacterial | 1 | 2002 | 1146 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 2019 | 999 | 0.030 |
Why?
|
| Calcinosis | 1 | 2005 | 1479 | 0.030 |
Why?
|
| Cardiovascular System | 1 | 2004 | 841 | 0.030 |
Why?
|
| Blood Glucose | 2 | 2008 | 6424 | 0.030 |
Why?
|
| Eye Color | 1 | 1996 | 35 | 0.030 |
Why?
|
| Shock, Hemorrhagic | 1 | 2018 | 225 | 0.030 |
Why?
|
| Inappropriate Prescribing | 1 | 2019 | 211 | 0.030 |
Why?
|
| Government Agencies | 1 | 2017 | 161 | 0.030 |
Why?
|
| Mexico | 1 | 2019 | 777 | 0.030 |
Why?
|
| Intention to Treat Analysis | 1 | 2017 | 416 | 0.030 |
Why?
|
| Vancomycin | 1 | 2019 | 504 | 0.030 |
Why?
|
| Protein Kinase C | 1 | 2001 | 1202 | 0.030 |
Why?
|
| Antibodies, Bacterial | 1 | 2002 | 1476 | 0.030 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2006 | 1434 | 0.030 |
Why?
|
| Skin | 1 | 2010 | 4489 | 0.030 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2017 | 215 | 0.030 |
Why?
|
| Drug Therapy | 1 | 1999 | 504 | 0.030 |
Why?
|
| Acute Disease | 2 | 2020 | 7232 | 0.030 |
Why?
|
| Genes, ras | 1 | 1999 | 658 | 0.030 |
Why?
|
| Family Planning Services | 1 | 2019 | 278 | 0.030 |
Why?
|
| Postnatal Care | 1 | 2018 | 275 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2011 | 4533 | 0.030 |
Why?
|
| Vermont | 1 | 2016 | 80 | 0.030 |
Why?
|
| Spouses | 1 | 2018 | 288 | 0.030 |
Why?
|
| Ethanol | 1 | 2022 | 1323 | 0.030 |
Why?
|
| Menogaril | 1 | 1995 | 4 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2012 | 6547 | 0.030 |
Why?
|
| Oceania | 1 | 2015 | 21 | 0.030 |
Why?
|
| Cuba | 1 | 2015 | 48 | 0.030 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2002 | 845 | 0.030 |
Why?
|
| Neuroblastoma | 1 | 2004 | 1263 | 0.030 |
Why?
|
| Self Care | 1 | 2021 | 800 | 0.030 |
Why?
|
| Haiti | 1 | 2017 | 553 | 0.030 |
Why?
|
| Self-Assessment | 1 | 2018 | 400 | 0.030 |
Why?
|
| Precancerous Conditions | 1 | 2002 | 976 | 0.030 |
Why?
|
| Americas | 1 | 2015 | 109 | 0.030 |
Why?
|
| Life Tables | 1 | 1996 | 363 | 0.030 |
Why?
|
| Moldova | 1 | 2015 | 14 | 0.030 |
Why?
|
| Ultrasonography | 5 | 2010 | 5993 | 0.030 |
Why?
|
| Costa Rica | 1 | 2015 | 186 | 0.030 |
Why?
|
| Laboratories, Hospital | 1 | 2017 | 193 | 0.030 |
Why?
|
| Bleomycin | 1 | 1996 | 491 | 0.030 |
Why?
|
| Artifacts | 1 | 2024 | 1893 | 0.030 |
Why?
|
| Respiratory Tract Diseases | 2 | 2002 | 744 | 0.030 |
Why?
|
| Pain | 2 | 2023 | 5077 | 0.030 |
Why?
|
| Health Care Rationing | 1 | 1998 | 436 | 0.030 |
Why?
|
| Gastrostomy | 1 | 2018 | 327 | 0.030 |
Why?
|
| Death, Sudden, Cardiac | 2 | 2019 | 1568 | 0.030 |
Why?
|
| Hypercholesterolemia | 1 | 2002 | 1149 | 0.030 |
Why?
|
| Oligonucleotides | 2 | 2008 | 561 | 0.030 |
Why?
|
| Frail Elderly | 1 | 2020 | 785 | 0.030 |
Why?
|
| Death | 1 | 2020 | 686 | 0.030 |
Why?
|
| Michigan | 1 | 2016 | 328 | 0.030 |
Why?
|
| Diagnostic Errors | 1 | 2022 | 1275 | 0.030 |
Why?
|
| Community Health Services | 1 | 2000 | 657 | 0.030 |
Why?
|
| Tissue Adhesions | 1 | 2016 | 220 | 0.030 |
Why?
|
| Vascular Patency | 2 | 2008 | 912 | 0.030 |
Why?
|
| Fetal Death | 1 | 2016 | 435 | 0.030 |
Why?
|
| Radiotherapy Dosage | 2 | 2016 | 2865 | 0.030 |
Why?
|
| Puerperal Disorders | 1 | 2017 | 306 | 0.030 |
Why?
|
| Women's Health | 3 | 2009 | 2084 | 0.030 |
Why?
|
| Cocaine | 1 | 2020 | 946 | 0.030 |
Why?
|
| Chile | 1 | 2015 | 258 | 0.030 |
Why?
|
| Wound Healing | 2 | 2019 | 2792 | 0.030 |
Why?
|
| Intraoperative Period | 1 | 2015 | 508 | 0.030 |
Why?
|
| Health Personnel | 2 | 2023 | 3390 | 0.030 |
Why?
|
| Systems Integration | 1 | 2016 | 427 | 0.030 |
Why?
|
| Critical Pathways | 1 | 2018 | 474 | 0.030 |
Why?
|
| Obstetrics | 2 | 2013 | 680 | 0.030 |
Why?
|
| Time | 1 | 2016 | 550 | 0.030 |
Why?
|
| China | 2 | 2015 | 2385 | 0.030 |
Why?
|
| Hydrogels | 1 | 2019 | 728 | 0.030 |
Why?
|
| Ribavirin | 1 | 1996 | 395 | 0.030 |
Why?
|
| Direct Service Costs | 1 | 2014 | 61 | 0.030 |
Why?
|
| Xerophthalmia | 1 | 1993 | 12 | 0.030 |
Why?
|
| Nursing Records | 1 | 2013 | 32 | 0.030 |
Why?
|
| Equipment and Supplies, Hospital | 1 | 2014 | 55 | 0.030 |
Why?
|
| Equipment Failure Analysis | 1 | 2016 | 834 | 0.030 |
Why?
|
| El Salvador | 1 | 2013 | 34 | 0.030 |
Why?
|
| Vitamin A Deficiency | 1 | 1994 | 88 | 0.030 |
Why?
|
| Nursing Informatics | 1 | 2013 | 46 | 0.030 |
Why?
|
| Vital Statistics | 1 | 2013 | 31 | 0.030 |
Why?
|
| Exercise | 2 | 2020 | 5937 | 0.030 |
Why?
|
| Osteosarcoma | 2 | 1996 | 909 | 0.030 |
Why?
|
| Interferon-beta | 1 | 1995 | 346 | 0.030 |
Why?
|
| Biopsy | 2 | 2019 | 6763 | 0.030 |
Why?
|
| Infant, Premature | 1 | 2023 | 2122 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2019 | 1971 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2019 | 2108 | 0.030 |
Why?
|
| Colon | 1 | 2021 | 1795 | 0.030 |
Why?
|
| Graft Rejection | 2 | 2010 | 4499 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2015 | 566 | 0.030 |
Why?
|
| Feedback, Psychological | 1 | 2012 | 97 | 0.020 |
Why?
|
| Information Systems | 1 | 2014 | 400 | 0.020 |
Why?
|
| France | 1 | 2013 | 495 | 0.020 |
Why?
|
| Disease Progression | 4 | 2006 | 13632 | 0.020 |
Why?
|
| Myocardium | 2 | 2012 | 4760 | 0.020 |
Why?
|
| Adenoma, Islet Cell | 1 | 1992 | 72 | 0.020 |
Why?
|
| Constriction | 1 | 2012 | 166 | 0.020 |
Why?
|
| Curriculum | 2 | 2017 | 3782 | 0.020 |
Why?
|
| Hysterectomy | 1 | 2017 | 864 | 0.020 |
Why?
|
| Reimbursement, Incentive | 1 | 2017 | 541 | 0.020 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2019 | 1276 | 0.020 |
Why?
|
| Anxiety Disorders | 1 | 2023 | 2737 | 0.020 |
Why?
|
| Patient Care Planning | 1 | 2017 | 906 | 0.020 |
Why?
|
| Live Birth | 1 | 2015 | 516 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2019 | 1424 | 0.020 |
Why?
|
| Acetazolamide | 1 | 1992 | 98 | 0.020 |
Why?
|
| Decision Making | 2 | 2016 | 3965 | 0.020 |
Why?
|
| Perphenazine | 1 | 2011 | 32 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2012 | 10729 | 0.020 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2024 | 3356 | 0.020 |
Why?
|
| Lipids | 1 | 2022 | 3315 | 0.020 |
Why?
|
| Inflammation | 1 | 2011 | 10850 | 0.020 |
Why?
|
| Societies, Medical | 2 | 2016 | 3956 | 0.020 |
Why?
|
| Anesthesia Department, Hospital | 1 | 2011 | 69 | 0.020 |
Why?
|
| Hospital Departments | 1 | 2011 | 135 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2006 | 3446 | 0.020 |
Why?
|
| Exercise Test | 2 | 2012 | 2180 | 0.020 |
Why?
|
| Economics, Hospital | 1 | 1993 | 208 | 0.020 |
Why?
|
| Malignant Hyperthermia | 1 | 2011 | 73 | 0.020 |
Why?
|
| Affect | 1 | 1999 | 1500 | 0.020 |
Why?
|
| Ownership | 1 | 2013 | 338 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2005 | 2895 | 0.020 |
Why?
|
| Nursing Methodology Research | 1 | 2010 | 63 | 0.020 |
Why?
|
| Dibenzothiazepines | 1 | 2011 | 101 | 0.020 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 1995 | 616 | 0.020 |
Why?
|
| Animals | 7 | 2023 | 168764 | 0.020 |
Why?
|
| Embolism, Air | 1 | 2011 | 111 | 0.020 |
Why?
|
| Organizational Culture | 1 | 2014 | 514 | 0.020 |
Why?
|
| Personality | 1 | 2014 | 560 | 0.020 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2012 | 299 | 0.020 |
Why?
|
| Reference Values | 2 | 2009 | 4908 | 0.020 |
Why?
|
| Awareness | 1 | 2015 | 653 | 0.020 |
Why?
|
| Coronary Artery Disease | 2 | 2012 | 6544 | 0.020 |
Why?
|
| Mitomycin | 2 | 2005 | 261 | 0.020 |
Why?
|
| Role Playing | 1 | 2010 | 21 | 0.020 |
Why?
|
| Cyclophosphamide | 1 | 1996 | 2228 | 0.020 |
Why?
|
| Fat Necrosis | 1 | 2010 | 59 | 0.020 |
Why?
|
| Africa, Northern | 1 | 2010 | 85 | 0.020 |
Why?
|
| Photography | 1 | 2013 | 533 | 0.020 |
Why?
|
| Urban Population | 2 | 2009 | 2040 | 0.020 |
Why?
|
| Liability, Legal | 1 | 1992 | 209 | 0.020 |
Why?
|
| Epigastric Arteries | 1 | 2010 | 93 | 0.020 |
Why?
|
| Transferrin | 1 | 2011 | 283 | 0.020 |
Why?
|
| Arthritis, Rheumatoid | 3 | 1999 | 3733 | 0.020 |
Why?
|
| Endoscopy | 1 | 2020 | 1841 | 0.020 |
Why?
|
| Social Class | 2 | 2016 | 2007 | 0.020 |
Why?
|
| Software Design | 1 | 1990 | 173 | 0.020 |
Why?
|
| Double-Blind Method | 3 | 2010 | 12437 | 0.020 |
Why?
|
| Housekeeping, Hospital | 1 | 2009 | 18 | 0.020 |
Why?
|
| Utilization Review | 1 | 2011 | 381 | 0.020 |
Why?
|
| Consensus | 1 | 2019 | 3202 | 0.020 |
Why?
|
| Swine | 1 | 2019 | 5988 | 0.020 |
Why?
|
| New Zealand | 1 | 2010 | 359 | 0.020 |
Why?
|
| Kidney Function Tests | 1 | 2012 | 683 | 0.020 |
Why?
|
| Middle East | 1 | 2010 | 237 | 0.020 |
Why?
|
| Ligation | 1 | 2010 | 444 | 0.020 |
Why?
|
| Lymphoma, B-Cell | 1 | 2016 | 943 | 0.020 |
Why?
|
| Urinary Tract Infections | 1 | 2016 | 805 | 0.020 |
Why?
|
| Urinary Catheterization | 1 | 2010 | 195 | 0.020 |
Why?
|
| Mental Disorders | 2 | 1999 | 6853 | 0.020 |
Why?
|
| Hernia, Abdominal | 1 | 2010 | 58 | 0.020 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2011 | 394 | 0.020 |
Why?
|
| Radiography | 2 | 2011 | 6919 | 0.020 |
Why?
|
| Specialty Boards | 1 | 2011 | 234 | 0.020 |
Why?
|
| Genetic Counseling | 1 | 2013 | 634 | 0.020 |
Why?
|
| Puerto Rico | 1 | 2010 | 381 | 0.020 |
Why?
|
| Traction | 1 | 2009 | 112 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2002 | 3807 | 0.020 |
Why?
|
| Students, Medical | 2 | 2014 | 1959 | 0.020 |
Why?
|
| Diastole | 2 | 2002 | 785 | 0.020 |
Why?
|
| Gastrointestinal Diseases | 1 | 2017 | 1203 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2017 | 1672 | 0.020 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 1992 | 335 | 0.020 |
Why?
|
| Blue Cross Blue Shield Insurance Plans | 1 | 2009 | 92 | 0.020 |
Why?
|
| Switzerland | 1 | 2009 | 322 | 0.020 |
Why?
|
| Vocal Cord Paralysis | 1 | 2012 | 275 | 0.020 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2010 | 103 | 0.020 |
Why?
|
| Latin America | 1 | 2010 | 416 | 0.020 |
Why?
|
| Tissue Expansion Devices | 1 | 2010 | 159 | 0.020 |
Why?
|
| ROC Curve | 2 | 2011 | 3620 | 0.020 |
Why?
|
| Rats, Inbred Lew | 1 | 2010 | 1167 | 0.020 |
Why?
|
| Organizational Policy | 1 | 2011 | 434 | 0.020 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2005 | 855 | 0.020 |
Why?
|
| Poverty Areas | 1 | 2010 | 268 | 0.020 |
Why?
|
| Group Processes | 1 | 2010 | 224 | 0.020 |
Why?
|
| Breast | 1 | 2017 | 1946 | 0.020 |
Why?
|
| Europe | 1 | 2015 | 3423 | 0.020 |
Why?
|
| Self Disclosure | 1 | 2009 | 248 | 0.020 |
Why?
|
| Program Development | 1 | 2014 | 1295 | 0.020 |
Why?
|
| Apgar Score | 1 | 2008 | 124 | 0.020 |
Why?
|
| Age of Onset | 2 | 2011 | 3344 | 0.020 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2014 | 1237 | 0.020 |
Why?
|
| Anxiety | 1 | 2023 | 4671 | 0.020 |
Why?
|
| Medically Underserved Area | 1 | 2010 | 266 | 0.020 |
Why?
|
| Disclosure | 1 | 2014 | 756 | 0.020 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2015 | 1354 | 0.020 |
Why?
|
| Spinal Cord Injuries | 1 | 2015 | 927 | 0.020 |
Why?
|
| Dissection | 1 | 2009 | 299 | 0.020 |
Why?
|
| Health Plan Implementation | 1 | 2011 | 338 | 0.020 |
Why?
|
| Licensure, Medical | 1 | 2008 | 72 | 0.020 |
Why?
|
| Marriage | 1 | 2009 | 351 | 0.020 |
Why?
|
| Exercise Therapy | 1 | 2014 | 937 | 0.020 |
Why?
|
| Cerebrovascular Disorders | 1 | 2014 | 1470 | 0.020 |
Why?
|
| Receptor, Angiotensin, Type 2 | 1 | 2007 | 61 | 0.020 |
Why?
|
| Africa South of the Sahara | 1 | 2010 | 751 | 0.020 |
Why?
|
| Lung Diseases | 1 | 2017 | 1940 | 0.020 |
Why?
|
| Mass Media | 1 | 2010 | 301 | 0.020 |
Why?
|
| Policy Making | 1 | 2011 | 546 | 0.020 |
Why?
|
| Paclitaxel | 1 | 1995 | 1728 | 0.020 |
Why?
|
| Parenteral Nutrition | 1 | 2012 | 660 | 0.020 |
Why?
|
| Risk Reduction Behavior | 1 | 2014 | 1123 | 0.020 |
Why?
|
| Developed Countries | 1 | 2010 | 452 | 0.020 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2011 | 363 | 0.020 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2007 | 91 | 0.020 |
Why?
|
| Diet, Sodium-Restricted | 1 | 2009 | 291 | 0.020 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 1995 | 961 | 0.020 |
Why?
|
| Hormones | 1 | 2011 | 863 | 0.020 |
Why?
|
| Home Care Services | 1 | 2013 | 660 | 0.020 |
Why?
|
| Negotiating | 1 | 2008 | 152 | 0.020 |
Why?
|
| Taiwan | 2 | 1998 | 521 | 0.020 |
Why?
|
| Anastomosis, Surgical | 1 | 2010 | 990 | 0.020 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2007 | 208 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 2013 | 1707 | 0.020 |
Why?
|
| Gestational Age | 1 | 2015 | 3609 | 0.020 |
Why?
|
| Physician Assistants | 1 | 2009 | 190 | 0.020 |
Why?
|
| Wisconsin | 1 | 2006 | 121 | 0.020 |
Why?
|
| Seizures | 1 | 2019 | 3000 | 0.020 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2008 | 193 | 0.020 |
Why?
|
| Australia | 1 | 2010 | 1258 | 0.020 |
Why?
|
| Thyroidectomy | 1 | 2012 | 916 | 0.020 |
Why?
|
| Scientific Misconduct | 1 | 2007 | 77 | 0.020 |
Why?
|
| Hemodynamics | 2 | 2008 | 4184 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 2013 | 1534 | 0.020 |
Why?
|
| Recurrence | 2 | 2010 | 8501 | 0.020 |
Why?
|
| Breast Implants | 1 | 2010 | 411 | 0.020 |
Why?
|
| Research Support as Topic | 1 | 2010 | 696 | 0.020 |
Why?
|
| Counseling | 1 | 2014 | 1551 | 0.020 |
Why?
|
| Urologic Surgical Procedures | 1 | 2008 | 281 | 0.020 |
Why?
|
| Hospitals, Private | 1 | 2006 | 66 | 0.020 |
Why?
|
| Necrosis | 1 | 2010 | 1617 | 0.020 |
Why?
|
| Models, Educational | 1 | 2008 | 376 | 0.020 |
Why?
|
| Pericardium | 1 | 2010 | 679 | 0.020 |
Why?
|
| Withholding Treatment | 1 | 2010 | 621 | 0.020 |
Why?
|
| Electric Impedance | 1 | 2010 | 794 | 0.020 |
Why?
|
| Specimen Handling | 1 | 2010 | 704 | 0.020 |
Why?
|
| Body Temperature | 1 | 2008 | 779 | 0.020 |
Why?
|
| Accreditation | 1 | 2008 | 477 | 0.020 |
Why?
|
| Social Environment | 1 | 2010 | 1011 | 0.010 |
Why?
|
| Penicillamine | 1 | 2005 | 59 | 0.010 |
Why?
|
| Memory | 1 | 2014 | 2190 | 0.010 |
Why?
|
| Anesthesia | 1 | 2016 | 1590 | 0.010 |
Why?
|
| Heart Rate | 2 | 2008 | 4204 | 0.010 |
Why?
|
| Prosthesis Failure | 1 | 2010 | 1191 | 0.010 |
Why?
|
| Immediate-Early Proteins | 1 | 2007 | 444 | 0.010 |
Why?
|
| Catheterization, Central Venous | 1 | 2009 | 539 | 0.010 |
Why?
|
| Cervix Uteri | 1 | 2008 | 579 | 0.010 |
Why?
|
| Device Removal | 1 | 2009 | 646 | 0.010 |
Why?
|
| Focus Groups | 1 | 2010 | 1459 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2000 | 4044 | 0.010 |
Why?
|
| Antigen-Antibody Complex | 1 | 2006 | 508 | 0.010 |
Why?
|
| Cardiomyopathy, Restrictive | 1 | 2004 | 61 | 0.010 |
Why?
|
| Catheterization | 1 | 2009 | 1425 | 0.010 |
Why?
|
| Anaphylaxis | 1 | 2011 | 739 | 0.010 |
Why?
|
| Tissue Scaffolds | 1 | 2010 | 934 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 1996 | 2567 | 0.010 |
Why?
|
| Sudan | 2 | 1994 | 86 | 0.010 |
Why?
|
| Mice | 4 | 2009 | 81819 | 0.010 |
Why?
|
| Geography | 1 | 2006 | 652 | 0.010 |
Why?
|
| Gynecology | 1 | 2009 | 535 | 0.010 |
Why?
|
| Environmental Exposure | 1 | 1998 | 4544 | 0.010 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2007 | 497 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2005 | 1377 | 0.010 |
Why?
|
| Hypopituitarism | 1 | 2005 | 254 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2006 | 1701 | 0.010 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2015 | 2187 | 0.010 |
Why?
|
| Lipoproteins, LDL | 1 | 2006 | 643 | 0.010 |
Why?
|
| Chelating Agents | 1 | 2004 | 380 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1995 | 2329 | 0.010 |
Why?
|
| Japan | 1 | 2007 | 1415 | 0.010 |
Why?
|
| Heart Block | 1 | 2004 | 391 | 0.010 |
Why?
|
| Renin-Angiotensin System | 1 | 2007 | 737 | 0.010 |
Why?
|
| Mental Recall | 1 | 2009 | 1218 | 0.010 |
Why?
|
| Floxuridine | 1 | 2002 | 44 | 0.010 |
Why?
|
| Medicine | 1 | 2010 | 942 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2007 | 1628 | 0.010 |
Why?
|
| Hypotension | 1 | 2008 | 885 | 0.010 |
Why?
|
| Fatigue | 1 | 2009 | 1549 | 0.010 |
Why?
|
| Hospital Records | 2 | 1993 | 93 | 0.010 |
Why?
|
| Colorado | 1 | 2002 | 167 | 0.010 |
Why?
|
| Peritoneal Dialysis | 1 | 2003 | 161 | 0.010 |
Why?
|
| Low Back Pain | 1 | 2010 | 987 | 0.010 |
Why?
|
| Tachycardia | 1 | 2004 | 594 | 0.010 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2002 | 218 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2017 | 3458 | 0.010 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2001 | 43 | 0.010 |
Why?
|
| International Classification of Diseases | 1 | 2007 | 935 | 0.010 |
Why?
|
| Fetal Blood | 1 | 2008 | 1369 | 0.010 |
Why?
|
| Hyperparathyroidism | 1 | 2003 | 337 | 0.010 |
Why?
|
| Thorax | 1 | 2004 | 554 | 0.010 |
Why?
|
| Secondary Prevention | 1 | 2007 | 1472 | 0.010 |
Why?
|
| Multiple Myeloma | 1 | 1999 | 5197 | 0.010 |
Why?
|
| Hepatic Artery | 1 | 2002 | 231 | 0.010 |
Why?
|
| Anthropometry | 1 | 2005 | 1338 | 0.010 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2006 | 1093 | 0.010 |
Why?
|
| Tissue Donors | 1 | 2010 | 2395 | 0.010 |
Why?
|
| Anemia | 1 | 2010 | 1511 | 0.010 |
Why?
|
| Cisplatin | 2 | 1996 | 1658 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2007 | 1657 | 0.010 |
Why?
|
| Tomography, Emission-Computed | 1 | 2003 | 1006 | 0.010 |
Why?
|
| Patient Transfer | 1 | 2007 | 790 | 0.010 |
Why?
|
| Graft Survival | 1 | 2010 | 3890 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2010 | 3561 | 0.010 |
Why?
|
| Pediatrics | 1 | 2014 | 3606 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2001 | 1546 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 1998 | 5849 | 0.010 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2008 | 1085 | 0.010 |
Why?
|
| Agranulocytosis | 1 | 1999 | 99 | 0.010 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2001 | 755 | 0.010 |
Why?
|
| Heart Conduction System | 1 | 2004 | 1006 | 0.010 |
Why?
|
| Placebos | 1 | 2003 | 1659 | 0.010 |
Why?
|
| Body Height | 1 | 2005 | 1562 | 0.010 |
Why?
|
| Epidemiologic Research Design | 1 | 2002 | 368 | 0.010 |
Why?
|
| Genotype | 1 | 2013 | 13024 | 0.010 |
Why?
|
| Thrombin | 1 | 2001 | 602 | 0.010 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2001 | 462 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2003 | 1718 | 0.010 |
Why?
|
| Connecticut | 1 | 1999 | 365 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2010 | 3312 | 0.010 |
Why?
|
| Triglycerides | 1 | 2006 | 2441 | 0.010 |
Why?
|
| Electrocardiography | 2 | 2004 | 6404 | 0.010 |
Why?
|
| Antibodies | 1 | 2006 | 2417 | 0.010 |
Why?
|
| Life Style | 1 | 2009 | 3926 | 0.010 |
Why?
|
| Antipsychotic Agents | 1 | 2011 | 3076 | 0.010 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2006 | 3675 | 0.010 |
Why?
|
| Weight Loss | 1 | 2009 | 2710 | 0.010 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2007 | 1404 | 0.010 |
Why?
|
| Patient Dropouts | 1 | 1999 | 410 | 0.010 |
Why?
|
| Codon | 1 | 1999 | 595 | 0.010 |
Why?
|
| Respiratory Tract Infections | 1 | 2004 | 1008 | 0.010 |
Why?
|
| Leucovorin | 1 | 1999 | 641 | 0.010 |
Why?
|
| Urbanization | 1 | 1997 | 101 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2021 | 12240 | 0.010 |
Why?
|
| Pulmonary Diffusing Capacity | 1 | 1996 | 93 | 0.010 |
Why?
|
| Total Lung Capacity | 1 | 1996 | 148 | 0.010 |
Why?
|
| Dactinomycin | 1 | 1996 | 304 | 0.010 |
Why?
|
| Stomatitis | 1 | 1999 | 270 | 0.010 |
Why?
|
| Overweight | 1 | 2007 | 2444 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1996 | 412 | 0.010 |
Why?
|
| Nutritional Status | 2 | 1994 | 1620 | 0.010 |
Why?
|
| Aspartate Aminotransferases | 1 | 1996 | 415 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 11022 | 0.010 |
Why?
|
| Fever | 1 | 2002 | 1603 | 0.010 |
Why?
|
| Rats | 1 | 2010 | 23707 | 0.010 |
Why?
|
| Mutation | 1 | 1999 | 30198 | 0.010 |
Why?
|
| Medical Indigency | 1 | 1993 | 63 | 0.010 |
Why?
|
| Renal Dialysis | 1 | 2003 | 1799 | 0.010 |
Why?
|
| Sleep | 1 | 2009 | 4813 | 0.010 |
Why?
|
| Financial Management, Hospital | 1 | 1993 | 70 | 0.010 |
Why?
|
| Air Pollutants | 1 | 2006 | 2923 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2007 | 14448 | 0.010 |
Why?
|
| Kidney | 1 | 2007 | 7066 | 0.010 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 1993 | 292 | 0.010 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2007 | 3646 | 0.010 |
Why?
|
| Forced Expiratory Volume | 1 | 1996 | 1828 | 0.010 |
Why?
|
| Remission Induction | 1 | 1996 | 2411 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2001 | 4159 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2002 | 4528 | 0.010 |
Why?
|
| Cough | 1 | 1994 | 597 | 0.010 |
Why?
|
| Methotrexate | 1 | 1996 | 1722 | 0.010 |
Why?
|
| Hospitals, Rural | 1 | 1991 | 175 | 0.010 |
Why?
|
| Neutropenia | 1 | 1995 | 893 | 0.010 |
Why?
|
| Radiotherapy | 1 | 1996 | 1494 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2002 | 3837 | 0.000 |
Why?
|
| Antirheumatic Agents | 1 | 1999 | 1365 | 0.000 |
Why?
|
| Tumor Cells, Cultured | 1 | 1996 | 6113 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 2007 | 18293 | 0.000 |
Why?
|
| Diarrhea | 1 | 1994 | 1316 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 2001 | 12768 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 2001 | 18973 | 0.000 |
Why?
|
| Signal Transduction | 1 | 2001 | 23601 | 0.000 |
Why?
|